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ABSTRACT
EVALUATION OF A BIOPROCESSED SOYBEAN MEAL ON NURSERY PIG
IMMUNE STATUS AND DISEASE RESISTANCE
JACOB R. KOEPKE
2017
Weaning is a stressful time in a piglet’s life that can have negative impacts on
performance and health if not managed properly. The objective of this research was to
evaluate the effects of a bioprocessed SBM alone or in combination with spray-dried
plasma (SDP) or fishmeal (FM) on immune response at weaning with no imminent
disease threat and during a porcine reproductive and respiratory virus (PRRSV)
challenge. In the first trial, 239 pigs (initial BW 6.56 ± 0.87 kg, 21 d of age) were used in
a 35-d study and allotted to one of 4 dietary treatments (10 pens/trt) according to initial
BW and sex: positive control (CON; corn/SBM diet) containing SDP and FM, the CON
with bioprocessed SBM replacing FM (BPSBM+SDP), the CON with bioprocessed SBM
replacing SDP (BPSBM+FM), and the CON with bioprocessed SBM replacing SDP and
FM (BPSBM). Experimental diets were fed in Phase I (d 1-7 after weaning) and II (d 821) followed by a common Phase III diet (d 22-35). Assessment of immune response
was based on mitogenic lymphocyte proliferation and dermal hypersensitivity and antiIgG assay to previously sensitized antigens. Pigs fed CON were heavier (P<0.01) than
pigs fed BPSBM+FM and BPSBM, and not different from pigs fed BPSBM+SDP, at the end
of Phase I and II (6.99, 6.80, 6.52, or 6.60 kg, pooled SEM 0.08, respectively in Phase I
or 12.47, 12.18, 11.42, and 11.85 kg, pooled SEM 0.21, in Phase II, respectively). There
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was no difference in lymphocyte proliferation or dermal hypersensitivity due to
experimental diet. Secondary anti-OVA IgG was 2-fold lower based on optical density
values in pigs fed CON compared with BPSBM+FM and BPSBM (0.78 vs. 1.56 and 1.55,
pooled SEM 0.42 OD405nm, respectively). In the second trial, a total of 72 barrows (initial
BW 6.68 ± 0.15 kg, 21 d of age) were used in a 21-d study (-7 to 14 d post-inoculation,
DPI) with 48 PRRSV infected (POS) and 24 uninfected (SHAM) pigs. All pigs were
housed individually (12 pigs/room) with POS and SHAM pigs in separate buildings and
no staff transfer between buildings. POS pigs were allotted to one of the 4 diets from the
first trial and SHAM pigs were allotted to either the CON or BPSBM diets. Experimental
diets were fed in Phase I (-7 to 0 DPI) and II (1 to 14 DPI). On -7 DPI, SHAM pigs were
vaccinated with a commercial porcine circovirus (PCV2) vaccine for determination of
PCV2 neutralizing antibodies. On 0 DPI, POS pigs received a 1 x 105 tissue culture
infective dose of PRRSV (NADC20) diluted in 1 mL of cell culture media. Body weight
and rectal temperature were measured, and a blood sample collected on 0, 3, 7, 10, and
14 DPI. At 14 DPI, all pigs were euthanized and the lungs were removed for gross and
microscopic lesion scoring. SHAM pigs had negative serum virus titers at all timepoints
while POS pigs had positive serum virus titers at 3, 7, 10, and 14 DPI. POS pigs had
higher rectal temperatures at 3 DPI (39.5 vs. 38.9, pooled SEM 0.09 °C, P < 0.001).
Dietary treatment did not impact growth performance or serum virus load at any time
point. In SHAM pigs, pigs fed BPSBM had a greater proportion of pigs (P < 0.05) with
high levels of circulating PCV2 neutralizing antibodies compared to CON-fed pigs. The
similar growth performance in pigs from both trials indicates that bioprocessed SBM can
successfully replace SDP or FM and the positive impact of bioprocessed SBM on
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adaptive immune response indicates potential improved disease protection within
commercial vaccination programs.
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Chapter 1

1.0 LITERATURE REVIEW
Weaning is defined as “the phase of parental care in which parental investment
drops most sharply” (Martin, 1984). For pigs reared in semi-natural environments, this
process is gradual and can occur anywhere from 12 to 17 weeks post-partum (Newberry
and Wood-Gush, 1988; Jensen and Recén, 1989). However, in current commercial
production systems in North America piglets are typically reared on the sow in a
farrowing crate and weaned at 3 weeks of age. During this process piglets and removed
from the sow and transported to a new facility, typically a nursery barn or wean to finish
barn. This management practice puts multiple stressors on young piglets including;
handling, transportation, a new environment, new pen mates, a change in diet
composition, exposure to dietary and environmental antigens, and increased pathogen
exposure. Together, this creates one of the most stressful times in a pig’s life and these
abrupt changes can have a significant negative impact on feed intake, growth, and piglet
health if not properly managed. This literature review will be focused on the immune
system of young pigs and how the inclusion of specialty ingredients is used to manage
the stresses of weaning.
1.1 Immune System
1.1.1 Anatomy
The immune system is the body’s defense against infectious organisms and
invaders such as foreign bacteria, viruses, parasites, fungi and other foreign antigens. It
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is a diverse system compromised of many different proteins and cells that work together
to monitor the body, detect, and destroy foreign pathogens. The immune system can be
divided into the innate immune system and the adaptive immune system. The innate
immune system is a primitive system that is non-specific and responds rapidly to foreign
invasion versus the adaptive immune system that targets specific pathogens and has a
lasting memory (Dempsey et al., 2003). Both of these systems are derived from
hematopoietic stem cells from the bone marrow that differentiate via hematopoiesis into
myeloid cells and lymphoid cells which play important roles in cell-mediated responses
of the innate and adaptive immunity, respectively. Some important organs that play a
role in the immune system include the lymph nodes, the thymus, and the spleen. Lymph
nodes are small kidney-shaped organs of the lymphatic system present throughout the
body which house lymphocytes and aid in identifying and fighting infection (Rothkötter,
2009). The thymus is the site of T cell development, an important lymphoid cell of the
adaptive immune system (Šinkora et al., 2000). The spleen plays an important role with
the immune system by removing old red blood cells, regulating leukocytes, and provides
a site for soluble antigen sampling (Mebius and Kraal, 2005). Together these organs
work with cells of the immune system to provide protection from foreign invasion.
1.1.2 Innate Immune System
The innate immune system is non-specific and can be thought of as the “first line”
of defense that respond quickly to foreign antigens and pathogens. This system can be
broken down into the non-inducible innate mechanisms and inducible innate immunity.
Non-inducible innate mechanisms are a system of barriers that protect the body form
foreign antigen or pathogen invasion. These barriers consist of the physical barriers like
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the skin and mucosal membranes and chemical barriers such as pH of stomach acid, and
dry salty skin. This is the “first line” of defense within the innate immune system. A
breech in any of these barriers results in antigen and pathogen exposure and recognition
by pathogen recognition receptors (PRR) found on cells of the innate immune system.
Pathogen recognition by PRR causes a cascade of plasma proteins to activate whose role
are to enhance inflammation, allow opsonization to occur, or cause the cell to lyse by
forming a membrane attack complex (Janeway Jr and Medzhitov, 2002) as reviewed by
(Dempsey et al., 2003). This cascade of plasma proteins is known as complement
activation and consists of three different pathways that each promote a separate outcome
mentioned above. Together, complement activation works with the cells of the innate
immune system to recognize and control foreign antigens and pathogens. Cells of the
innate immune system are derived from myeloid cells which differentiate into
erythrocytes, monocytes, granulocytes, and dendritic cells.
Cytokines are small soluble proteins produced in various cells of the immune
system in a response to antigen stimulus and are released to induce inflammation or
recruit other immune cells to the site of infection. These proteins are different from the
plasma proteins of the complement system mentioned previously, but aid in similar
functions. Upon release from macrophages, granulocytes, and other cytokine secreting
cells, cytokines are sensed by recognition receptors on the surfaces of various immune
cells which aid in communication and cell recruitment. Classical inflammatory cytokines
include tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6)
(Murtaugh, 1994). Each of these cytokines plays a different role during an immune
response and the type of infection dictates which cytokines and how much are secreted.
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Another member of the cytokine family, known as chemokines, help direct cell
trafficking, dendritic cell maturation, lymphocyte development, and generation of Thelper type 1 (Th1) and type 2 (Th2) adaptive immune responses (Rossi and Zlotnik,
2000) as reviewed by (Dempsey et al., 2003). These are a few of many different
cytokines that play important roles in modulating immune responses to foreign antigens
and pathogens.
Monocytes make up 2-10% of leukocytes and are produced in the bone marrow
before entering the bloodstream and then diffusing into tissues where they mature into
macrophages. Macrophages have different names depending on where they have
migrated and what tissues they reside in (Kupffer cells = macrophages of the liver,
osteoclasts = macrophages found in bone, alveolar macrophages found on the pulmonary
alveoli of lungs, etc). Regardless of where they are located, macrophages play a vital role
in the innate immune defense by phagocytizing foreign molecules, producing high levels
of cytokines and chemokines, recruitment of other macrophages, and antigen presentation
to adaptive immune cells. Production and secretion of cytokines such as Type I
interferons (IFN), IFN-γ, and TNF-α aid in the inflammation response and immune cell
regulation (Murray and Wynn, 2011). This puts other cells of the innate system on high
alert and draws them to the site of infection to prevent spread to other tissues of the body.
Macrophages are also capable antigen presenting cells (APC) with the presence of major
histocompatibility complex (MHC) class II receptors which allow them to present foreign
antigen to cells of the adaptive immune system. This communication is important for
initiating an adaptive immune response.
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Granulocytes circulate in the blood stream and are characterized by the presence
of granules in their cytoplasm which are generally released when triggered by
inflammation. There are three types of granulocytes including; basophils, eosinophils,
and neutrophils all of which are derived from myeloid cells. Basophils, eosinophils and a
fourth type of cell, the mast cell, are often studied in pig models focused on human
allergy. Basophils are one of the lowest circulating granulocytes at 1-2% of leukocytes
and are thought to play a role in host defense specifically against parasites; however,
many of the physiological roles of basophils remain unknown. Basophils play a role in
allergenic response through induction of a Th2 response with expression of MHC class II
molecules and IL-4 production in murine models. Like basophils, eosinophils are also
relatively low in circulating granulocytes at 1-6% of leukocytes and help protect the host
against parasites and undergo degranulation in the presence of IgE-coated parasites.
Degranulation produces a mixture of inflammatory and toxic mediators that lead to potent
oxidizing agents which aid in destruction of labeled parasites. Eosinophils also release
Th2 cytokines similar to basophils which plays a large part in the proposed allergenic
response of these granulocytes (Stone et al., 2010). The differences between mast cells
versus basophils and eosinophils are that mast cells remain in tissue rather than
circulating in the blood stream. Mast cells also release histamine, heparin, and other
proteases that aid in vasodilation and result in the release of Th2 pro-inflammatory
cytokines which aid in the cell-mediated immune response. Mast cells are often
associated with allergy symptoms due to their high-affinity receptors for the
immunoglobulin (Ig) IgE (Mekori and Metcalfe, 2000).
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Neutrophils are short lived, highly phagocytic cells that are the primary
leukocytes in circulation. They are typically the first cells at the site of infection and can
be activated by stimulation from chemokines and inflammatory cytokines such as
CXCL8 and TNF-α, respectively. As a member of the granulocyte family, neutrophils
are capable of degranulation by releasing a variety of enzymes that aid in destruction of
pathogen cell walls, activation of other resident cells, and a variety of other
immunomodulatory effects. Neutrophils are also capable of engulfing pathogens by
receptor-specific binding to antibody or complement-coated pathogens and forming
neutrophil extracellular traps which trap and destroy pathogens (Mantovani et al., 2011).
Dendritic cells (DC) are long-lived cells that play an important role in regulating
both the innate and adaptive immune systems. In their inactivated form, they travel the
body in the lymph to sites of inflammation in response to chemokine gradients and
cytokine signaling and are capable phagocytizing cells in the presence of pathogens.
Once activated by antigen uptake, they secrete cytokines that polarize T cells or induce
isotype switching in B cells as wells as activate other innate defenses (Summerfield and
McCullough, 2009). Further, DC are highly capable APC with the presence of MCH
class II molecules, like macrophages, that allow them to present foreign antigen to cells
of the adaptive immune system. They are capable of fully priming naïve T-helper cells as
well as continually priming proliferating B cells for production of plasma and memory B
cells (Wykes et al., 1998; Iwasaki and Kelsall, 2000). Dendritic cells play a pivotal role
in regulation of the innate and adaptive immune system.
1.1.3 Adaptive Immunity
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The adaptive immune system is different from the innate immune system because
it develops a memory and specific response to individual antigens. This memory and
rapid response to individual antigens is what separates the innate and adaptive immune
systems. Like the innate system, the adaptive system is comprised of a variety of cells as
well as large Y-shaped proteins known as Ig or antibodies (Ab). The primary cells of the
adaptive immune system are derived from lymphoid progenitor cells and consist of
natural killer cells, T lymphocytes (T cells) and B lymphocytes (B cells). Once activated,
T and B cells are able to provide antigenic specificity that define the adaptive immunity
and provide highly specific and lasting memory.
Natural killer cells (NK) are derived from the lymphocyte lineage; however, they
differ from T and B cells in the fact that they do not have specific memory (Kondo et al.,
1997). They can be found circulating in the blood and make up 2 – 10% of circulating
lymphocytes and decline with age. Although they are derived from lymphoid cells they
play an important role in the innate immune system by recognizing stressed or cancerous
cells in the absence of antibodies or MHC and sequentially lyse the stressed or cancerous
cells without prior sensitization (Yokoyama et al., 2004). They are also unique in the fact
that they do not attack pathogens directly, rather they destroy infected host cells by
releasing granzymes which forms pores in the cell membrane of the target cell and cause
apoptosis or osmotic cell lysis.
B lymphocytes develop in the bone marrow before migrating to the spleen and
lymph nodes where they become activated and diversify. Prior to activation B cells
undergo recombination of the variable, diversity, and joining gene fragments of the B cell
receptor which is only able to detect a single epitope (segment of antigen) and allows for
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highly specific detection. Each B cell is only able to become activated in the presence of
one specific epitope. Once activated B cells mature into plasma cells and are capable of
Ig production which begins with IgM (Butler et al., 2006). IgM is one of five large Yshaped protein isotypes that are secreted and able to bind to specific antigens and activate
macrophages from the innate immune system to destroy the labeled pathogen. Isotype
switching can occur after stimulation of T cell cytokines and other environmental stimuli
which shifts the production of IgM to other Igs (Coffman et al., 1993). Although there is
a shift from IgM to other Igs the new Ig class retains epitope specificity but results in B
lymphocytes interacting with different effector molecules. After isotype switching some
plasma B cells will become memory B cells that will persist in the body for years and
give a prompt and effective secondary response if the same antigen is encountered again.
There are 5 classes of immunoglobulins including; IgM, IgG, IgA, IgD, and IgE
which are produced by plasma and memory B cells, each with a different role in the
adaptive response (Butler et al., 2006). IgM is the first Ab produced in a primary
response and is found mainly in the serum but can also be secreted on mucosal surfaces.
IgM is unique because it is pentavalent with a total of 10 antigen binding sites but it has
relatively low affinity. It plays a large role in complement fixation by forming membrane
attack complex for target lysis and labeling pathogens for macrophages to engulf and
destroy. IgG is the workhorse of the humoral immune system and one of the most
common antibodies in circulation and tissues with a high affinity. IgG is important in
passive immunity as it is heavily concentrated in colostrum which provides some
protection for newly born animals. It acts by binding to Fc receptors and enhancing
phagocytosis by macrophages. IgA is found primarily in secretions such as mucusa in
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the gut, milk from mammary glands, tears, and saliva. IgA is very effective at
neutralizing toxins and pathogens but unlike IgG and IgM, IgA does not fix complement
and thus does not drive inflammation. Little is known about IgD, it is low in secretions
but may enhance mucosal immunity of the respiratory tract. IgE is well known for its
role in allergies and asthma in humans. It is produced in very small quantities but
induces potent effects and can degranulate eosinophils and basophils as well as release
histamine.
Like B cell receptors, T cells also express T cell receptors which undergo
rearrangement and selection which ultimately define them into two types of T cells.
These include α/β heterodimer and γ/δ heterodimer of which α/β heterodimer is
predominately found in the lymphoid tissues and the later in the blood and intestinal
epithelium. After positive or negative selection, the α/β heterodimer interacts with MHC
class I or MHC class II antigens that will define their subsequent phenotype as CD8 or
CD4 expression, respectively. The expression of CD4α/β heterodimer leads to
classification as Th and CD8α/β classification as cytotoxic T cell (CTL) (Yang and
Parkhouse, 1996) as reviewed by (Charerntantanakul and Roth, 2006). With each
classification comes a different role in the immune response, Th cells predominantly
occur in bacterial and parasitic infections whereas CTL cells predominate in antiviral
infections.
T-helper cells differentiate further into subtypes that play roles in inducing
inflammation, cell-mediated response, and humoral responses. The main T-helper
subsets are Th1 and Th2 which can either induce a cell-mediated immune response and
inflammation or a humoral immune response, respectively. Th1 cells move to the site of
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inflammation and stimulate macrophages and DC to produce IFN- γ, IL-2, and other
cytokines that boost a cell-mediated response. The Th1 response is generally geared
towards intracellular pathogens compared to extracellular pathogens which favor a Th2
response. During a Th2 response, Th2 cells move to mucosa and are presented antigens
from B cells which then promote a humoral response by stimulating the secretion of IL
cytokines. There are other T-helper subsets including Th9, Th17 and Th22 of which only
Th1, Th2 and Th17 have been identified in the pig (Raymond and Wilkie, 2004). The
antigen that is presented on MHC class II receptors of APC will dictate which subtype
response is elicited. And like B cells, Th cells can also be activated into memory Th cells
that allow for a rapid response when the same antigen is encountered again.
Cytotoxic T cells play a different role and recognize antigen in a MHC class Irestricted manner which leads to several outcomes. They are capable of proliferating and
secreting cytokines like IFNγ and TNFα as well as killing targeted cells. The γ/δ T cells
are the major T cell sub population in the peripheral blood lymphocytes of young pigs but
decrease with age. Their function is relatively unknown but they are thought to recognize
foreign antigens in a non-MHC-restricted manner. Cytotoxic T cells are capable of
responding to antigenic stimulation by proliferating and expressing cytokines such as IL1, IL-6, IL-8, and IFNα (Takamatsu et al., 2006) as reviewed by (Charerntantanakul and
Roth, 2006).
1.1.4 Fetal and Neonatal Immune Development
To understand what happens to a piglet’s immune system during weaning it is
important to know what has developed up until this significant time point. While in the
uterus the maternal blood supply is separated from the fetal blood supply by six layers.
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This prevents the transfer of immune cells and more specifically, antibodies to the fetus.
Therefore, colostrum and milk are the primary mechanisms by which passive transfer of
antibodies and other immune cells takes place, (Pastoret et al., 1998) as reviewed by
(Rothkötter, 2009). However, an event known as gut closure or the process by which
epithelial surfaces become impermeable to antigens, occurs around 24 – 36 hours postparturition (Weström et al., 1984). This inhibits the direct absorption of antibodies and
immune cells that are ingested in the colostrum. Although passive immunity is important
in protecting new born piglets they have developed much of their immune system preparturition. By as early as d 20, B cell receptor rearrangement has begun and by d 50 B
cells in the thymus are capable of spontaneous isotype switching from IgM to IgG
(Cukrowska et al., 1996). By d 60 – 80 lymphocytes start to migrate in large numbers to
the lymph nodes and spleen and by late gestation it is possible to recognize nearly all cell
types and tissues of the immune system (Šinkora and Butler, 2009). At this point in time,
they have developed all of the machinery with which to work but without antigen
exposure the system cannot fully develop and differentiate to sustain protection from
foreign pathogens.
At birth, piglets are immediately exposed to a great number of novel antigens in
the farrowing crate; however, they mount poor responses to these antigens. The lack of
response to such novel antigens is important because many of these antigens are harmless
bacteria that contribute to the commensal flora of the gastrointestinal (GI) tract that the
young animal will develop (Peng et al., 1989). Immediate protection is received through
passive immunity from maternal Ab in the colostrum but this protection lasts only a few
days (Speer et al., 1959). Because piglets cannot mount a proper immune response it is
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extremely important to keep farrowing facilities free of pathogenic bacteria and viruses
that could be detrimental to the young animals. Only a few days after birth APC and T
cells begin to migrate to the intestine and may express activation-associated molecules
that indicate the respective T cells have encountered foreign antigen. At 3 weeks of age
CD4+ T cells in the intestine are at levels comparable to mature adults but it will be
another 2 weeks for CD8+ T cells to mature to levels found in a mature pig. The high
levels of CD4+ T cells help to drive a Th1 or cellular response while the slower
developed CD8+ T cells will drive more of a Th2 or humoral response (Bailey et al.,
2005). The immune system is rapidly developing while the young pigs are still on the
sow; however, weaning will significantly increase antigen exposure by exposure of novel
antigens found in a new environment and new diet composition.
1.2 Impact of Weaning on Immunity
It is not uncommon to see a reduction in feed intake and performance the first
few days post-weaning while the piglets GI tract is developing and piglets are adapting to
the new solid feed (Bark et al., 1986; Lindemann et al., 1986). Reduction in growth
performance is compounded by an immature immune system that is trying to rapidly
build itself against the millions of new antigens and pathogens encountered in a new
environment and new feed source. One week prior to weaning and 2 to 3 weeks after
weaning can be thought of as an “immunity gap”, in which passive immunity received
from the sow is severely reduced and the pigs own adaptive immunity has not yet fully
developed (Fig. 1). It was reported by Salmon et al. (2009) that antibody absorption in
newborn pigs is significantly declined after 24 hours of age. This report is supported by
Brown et al. (1961) where they found that piglets had high antibody titers on the first day
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of life but significantly lower at 1 week of age and minimal levels at 4 weeks of age. It
was also reported that pigs weaned at 2 weeks of age had no differences in antibody titers
than those left on the sow at the end of 6 weeks. In another study, Miller et al. (1962)
reported a logarithmic decay in antibody absorption from colostrum after 1 day of age
and half-lives of 4.7 days. These reports demonstrate the “immunity gap” in which
passive immunity from the sow is significantly decreased by the time of weaning and
their own adaptive immunity is not yet sufficient for protection. During this “immunity
gap” piglets are rapidly developing Ab to foreign antigens which include the feed.
Antibodies can be found to fed proteins after weaning; however, a tolerance must be
achieved and is after a short transition period (Miller et al., 1994) as reviewed by (Bailey
et al., 2005).
Research of the innate immunity suggests that this system may also not yet be
able to sufficiently protect pigs weaned at an early age. The change in diet composition
at weaning also effects the innate immune system by foreign antigen recognition on PRR
of various myeloid cells. Recognition of foreign dietary antigens by PRR has been
reported to increase gene expression of inflammatory cytokines from 0 to 2 days postweaning and then returning to pre-weaning levels by day 8 in piglets weaned at 28 days
of age (Pié et al., 2004). Other reports indicate that the innate immune response is
reduced when piglets are weaned at an earlier age. Blecha et al. (1983) reported that
intradermal hypersensitivity, an indicator of cell-mediated immune response was reduced
in pigs weaned at 2 and 3 weeks of age compared to pigs weaned at 5 weeks old.
Similarly, lymphocyte proliferation, an indicator of T cell recruitment and proliferation
was decreased in pigs weaned at 2 and 3 weeks of age compared to pigs weaned at 5
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weeks of age. Despite weaning age, reports from Pié et al. (2004) indicate that weaning
will cause an increase in innate immune response but piglets weaned at an early age may
have an increased duration of response as observed by Blecha et al. (1983). The
increased antigen and pathogen exposure at weaning significantly effects how well the
immune system can respond but only so many variables can be controlled to try and
reduce environmental stimulus. One factor that can be more easily controlled is the
feedstuffs that comprise the diets in the first few weeks post weaning to help reduce
stress on the GI tract as well as the immune system.
1.3 Diet Composition
High quality amino acid sources are included in diets to help mitigate stress on the
GI tract and increase performance of pigs. Soybean meal (SBM) is generally thought of
as the standard amino acid source in swine diets in North America and much of the
world. It is an economical amino acid source derived from the seeds of the plant Glycine
max. Soybean seeds are harvested and then heated and pressed to extract the oil for
commodity use leaving behind a pressed cake that is dried and processed into a meal.
This SBM is then commonly included in swine diets or other livestock and aquaculture
feeds. The amino acid profile of SBM matches the amino acid requirement of pigs
extremely well compared to other cereal grains. However, SBM contains anti-nutritional
factors including; trypsin inhibitor, glycinin, beta-conglycinin, and others that can be
detrimental for a young pig due to the immature gastrointestinal tract (Li et al., 1990; Li
et al., 1991). Therefore, the amount of SBM in nursery diets are limited and other highly
digestible ingredients like dried-whey, spray-dried animal plasma (SDP), and fishmeal
(FM) are used to replace a portion of SBM for several weeks post-wean. However, these
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amino acid sources are expensive and therefore alternative highly digestible amino acid
sources are being sought to help reduce cost without negatively affecting growth
performance or health. Bio-processed soybean meals may be one such product that could
be a viable replacement for SDP or FM.
1.3.1 Dried-Whey
Dried-whey is usually added at high levels in early nursery diets, this allows
piglets to utilize the high quantities of lactase they are producing which aid in the
digestion of milk that contains high levels of fat and lactose (Klobasa et al., 1987).
Gradually, the weaned pig GI tract begins to produce higher quantities of protease,
amylase, maltase and sucrase that aid in the digestion of protein, starch, and simple
disaccharides present in traditional solid feed; however, these digestive enzymes are not
present in high quantities until 6 to 8 weeks of age (Hartma et al., 1961; Lindemann et al.,
1986). The inclusion of dried-whey aids in this transition by providing a highly
digestible and palatable ingredient in a ground diet that improves growth performance. It
has been reported to increase feed intake, growth, and gain to feed ratio when fed
immediately after weaning and for several weeks post-wean (Kornegay et al., 1974; Cera
et al., 1988; Lepine et al., 1991).
1.3.2 Spray-dried Animal Plasma
Spray-dried plasma is a highly digestible amino acid source that is derived from
either porcine or bovine origin and often incorporated in nursery diets for several weeks
post-wean. It has been reported that the inclusion of SDP at levels up to 6% increases
feed intake, average daily gain and reduced post-weaning diarrhea (Van Dijk et al.,

16
2001). The mode of action of how SDP increases feed intake is unclear; however, it has
been reported that SDP was more palatable compared to a diet containing dried skim milk
and therefore feed intake increased as did average daily gain (Ermer et al., 1994).
However, Torrallardona and Solà-Oriol (2009) reported that palatability of SDP was
intermediate compared to fourteen other protein sources and lower than that of FM.
Therefore, palatability may not play as much of a role in increased feed intake of SDP as
previously thought. It was proposed by Coffey and Cromwell (1995) that Igs present in
SDP of porcine origin may enhance piglet performance by preventing virus and bacteria
from damaging the gut wall. Ten years later Pierce et al. (2005) confirmed that the IgG
fraction of SDP of either bovine or porcine origin is responsible for the increase in
growth performance. It has also been proposed that increased feed intake of diets
containing SDP is due to a reduction in pro-inflammatory cytokines produced as the
results of a lower antigenic load. It has been well documented that the effects of SDP are
greater in poor sanitary conditions compared to clean, high health conditions (Coffey and
Cromwell, 1995; Bergström et al., 1997; Pierce et al., 2005). However, Touchette et al.
(2002) reported that pigs fed SDP had a greater response to lipopolysaccharide-induced
inflammatory cytokines which resulted in major damage to the mucosa of the
gastrointestinal tract and suggests that pigs fed SDP may be more susceptible to major
immunological challenges.
Concerns over disease transmission from porcine origin are a concern when
including SDP in all pig diets but especially weaned pig diets due to their immature
immune system. Patterson et al. (2010) reported that piglets consuming experimentally
produced SDP from porcine circovirus type 2 (PCV2) infected pigs became infected by
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14 days post-inoculation. However, it was also concluded that it was inappropriate to
fully extrapolate results from the experimentally produced SDP compared to
commercially produced SDP of healthy porcine origin. Other disease concerns include
porcine epidemic diarrhea virus (PEDV); however, Gerber et al. (2014) reported that risk
of PEDV transmission through commercially produced SDP of porcine origin is minimal
and the experimental spray-drying process was sufficient to inactivate infectious PEDV
in the plasma. Despite the benefits of feeding SDP, it is an expensive amino acid source
and economic evaluation is warranted before incorporating it in weaned pig’s diets.
1.3.3 Fishmeal
Fishmeal is another highly digestible amino acid source of animal origin included
in weaned pig diets. As the name suggests, fishmeal is derived from a variety of small
wild caught marine fish including menhaden, mackerel, and herring with menhaden being
the most common. The fish are cooked and then pressed allowing oil to be separated for
commodity use or inclusion in livestock feeds and a pressed cake remains. The pressed
cake is then dried to produce FM products that can be used in livestock and aquaculture
feeds (Vincent, 1976). Inclusion of FM in weaned pig diets is common and has been
reported to increase growth performance in the first few weeks post-wean (Stoner et al.,
1990; Kim and Easter, 2001). It has been reported that the inclusion of fish oil provides
immunological protection by reducing secretion of inflammatory cytokines like TNF-α
compared to pigs fed diets containing corn oil (Carroll et al., 2003). Gaines et al. (2003)
reported that inclusion of fish oil in simplified diets with no animal protein sources did
not alter immune response; however, pigs fed complex diets containing SDP had reduced
TNF-α levels. In a follow up study Gaines et al. (2005) reported that the inclusion of FM
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or fish oil altered acute phase immune response and the inclusion of FM may have led to
improved growth performance in pigs challenged with LPS. However, fishmeal is also
an expensive amino acid source due to limited supply from overfishing and competition
from aquaculture where it is often used as the sole amino acid source (Olsen and Hasan,
2012). Like SDP, an economic evaluation is warranted before incorporating FM into
weaned pig’s diets.
1.3.4 Bio-processed Soybean Meal
The bio-processing of SBM via fermentation, enzymatic conversion, or
inoculation and culturing processes have been reported to be an efficient method for
decreasing antinutritional factors while increasing CP and AA compared to conventional
SBM. Cervantes-Pahm and Stein (2010) reported that the SID of most AA in fermented
SBM (FSBM) and enzymatically-converted SBM (ESBM) was not greater than
conventional SBM; however, both FSBM and ESBM contained more digestible AA then
SBM. It was also reported that the SID of most AA in FSBM and ESBM was not
different from FM. Research conducted on a bio-processed soybean meal (BPSBM) by
Sinn et al. (2016) showed similar ileal digestible CP and AA compared to FM in both 30
kg and 10 kg pigs. The lack of difference between 10 kg and 30 kg pigs is important
because of the immature GI tract in the 10 kg pigs compared to 30 kg pigs. These reports
indicate that processed soybean meal is an effective replacement for SBM or FM based
on AA digestibility. It was also reported by Sinn et al. (2016) that BPSBM could be used
as an effective replacement for FM based on growth performance. The work done by
Sinn et al. (2016) supports research by Kim et al. (2010) where it was reported that
FSBM can be used to replace a portion of SBM and milk proteins without adverse effects
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on growth. A similar report from Jones et al. (2010) found that pigs fed FSBM in
combination with dried porcine solubles had an improved growth performance compared
to pigs fed diets with large concentrations of SBM or FM.
The impact of feeding FSBM, ESBM, and BPSBM on growth performance in
nursery pigs is well documented; however, understanding the impact on immune
response in nursery pigs is minimal. Zhou et al. (2011) reported an increase in weights of
thymus and mandibular lymph nodes as well as proportions of CD4+ and CD8+ T cells in
pigs fed ESBM compared to pigs fed SBM or soy protein isolate. This report indicates
that the ESBM fed had an impact on immune function of the pigs which appeared to be
beneficial and was supported by improved feed intake and weight gain. Roh et al. (2015)
reported a decrease in serum cortisol and expression of inflammatory genes from
leukocytes in pigs fed FSBM compared to pigs fed a control diet with SBM after an LPS
challenge. Again, there appeared to be a benefit of feeding FSBM on immune response
by potentially lowering the inflammatory response to an immune stimulation. It is
important to note that FM was used in both studies but was kept constant between the
experimental and control diets; therefore, results could be contributed to FM alone or the
effect of the combination with EBSM or FSBM. The purpose of research conducted for
this thesis was to study the effects of a novel BPSBM alone or in combination with SDP
and FM and the effects on immune response under two common immunological
challenges present in the pig industry: weaning with no imminent disease threat and
weaning during a PRRSV challenge.
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Figure 1. 1

Passive immunity from the sow severely declines after 1 week of age and steadily
declines through weaning at 3 weeks of age. The piglet’s immune system is slowly
maturing and is not able to sufficiently protect the animal from foreign antigens and
pathogens until around 6 weeks of age. This creates and “immunity gap” shortly before
and after weaning in which the piglet is at risk of infection.
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2.0 Evaluation of a bio-processed soybean meal on nursery pig performance and
immune status1
J. R. Koepke*, R. S. Kaushik†§, W. R. Gibbons†, M. Brown‡, C. L. Levesque*,2

*

Department of Animal Science, South Dakota State University, Brookings, SD,

†

Department of Biology and Microbiology, South Dakota State University, Brookings,

SD, ‡Department of Natural Resource Management, South Dakota State University,
Brookings, SD, and §Department of Veterinary and Biomedical Sciences, South Dakota
State University, Brookings, SD

1

The authors would like to acknowledge Prairie Aquatech (Brookings, SD, USA) for

provision of the BPSBM. Dr. Kim Koch of NDSU for mixing the diets. Research
supported by funds from South Dakota Soybean Research and Promotion Council (Sioux
Falls, SD, USA).
2

Corresponding author: crystal.levesque@sdstate.edu

2.1 ABSTRACT

A total of 239 pigs (initial BW 6.56 ± 0.87 kg, 21 d of age) were used in a 35-d
study to investigate the effects of fish meal (FM) and spray dried plasma (SDP) in
combination with a bioprocessed soybean meal (SBM) on growth performance and
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immune responses in weaned pigs. Equal numbers of barrows and gilts were randomly
allotted to 1 of 4 dietary treatments (10 pens/treatment) according to initial BW and sex:
positive control (CON; corn/SBM diet) containing SDP and FM, the CON with
bioprocessed SBM replacing FM (BPSBM+SDP), the CON with bioprocessed SBM
replacing SDP (BPSBM+FM), and the CON with bioprocessed SBM replacing both SDP
and FM (BPSBM). Experimental diets were fed in Phase I (d 1-7 post-wean) and II (d 821) followed by a common Phase III diet (d 22-35); changes in BW and feed
disappearance were determined accordingly. Pigs were sensitized against ovalbumin
(OVA) and Candida albicans (CAA) on d 7 and 21. Assessment of immune response was
based on lymphocyte proliferation in response to mitogens Concanavalin A and
phytohemagglutinin (d 14 post-wean), dermal hypersensitivity to OVA and CAA (%
increase in local swelling at 2, 6, 24, and 48 h post-injection) on d 28, and primary and
secondary anti-OVA IgG at d 21 and 28, respectively. Pigs fed CON were heavier
(P<0.01) than pigs fed BPSBM+FM and BPSBM, and not different from pigs fed
BPSBM+SDP, at the end of Phase I and II (6.99, 6.80, 6.52, or 6.60 kg, pooled SEM 0.08,
respectively in Phase I or 12.47, 12.18, 11.42, and 11.85 kg, pooled SEM 0.21, in Phase
II, respectively). Hypersensitivity to OVA peaked at 2h in pigs fed CON, BPSBM+SDP,
and BPSBM+FM or peaked at 6h in pigs fed BPSBM (121.4, 165.6, 139.0, and 144.1%,
pooled SEM 22.9, respectively, at 2 h and 86.7, 114.5, 95.0, and 156.8%, pooled SEM
29.4, respectively at 6 h). Peak response to CAA occurred at 2h in all groups (42.6, 55.2,
48.2, and 50.6%, pooled SEM 11.9, respectively, in the CON, BPSBM+SDP, BPSBM+FM,
and BPSBM, respectively). There was no difference in hypersensitivity due to
experimental diet at any time point. Secondary anti-OVA IgG was 2-fold lower based on
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optical density values in pigs fed CON compared with BPSBM+FM and BPSBM (0.78 vs.
1.56 and 1.55 optical density at 405 nm, pooled SEM 0.42, respectively). Dietary
treatment did not impact lymphocyte proliferation. The bioprocessed SBM is a suitable
alternative for FM and/or SDP in Phase I and II nursery diets based on pig growth. The
prolonged hypersensitivity to OVA indicate that bioprocessed SBM may have a positive
impact on pig immune function and the 2-fold increase in anti-OVA IgG warrants further
investigation on the impact of bioprocessed SBM on pig immune function.
Key words: alternative amino acids, bioprocessed soybean meal, immune response,
nursery pig, weaning

2.2 INTRODUCTION

Soybean meal (SBM) is a poorly tolerated protein source in the young pig’s
digestive tract due to anti-nutritional factors such as glycinin and beta-conglycinin that
can decrease performance and induce an immune response (Li et al., 1990; 1991). To
address this problem, antibiotics and highly digestible AA sources such as spray dried
plasma (SDP) and fish meal (FM) are incorporated into the diet to help increase feed
intake and improve piglet health (Cromwell, 2002; DeRouchey et al., 2010). However,
the cost of these products often limits producer’s ability to include them in an economical
nursery diet. Bio-processing or fermentation of plant proteins, specifically SBM, have
been shown to reduce anti-nutritional factors and can be fed to nursery pigs without
adversely affecting performance (Kim et al., 2010; Sinn et al., 2016).
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One such bioprocessed soybean meal, (Prairie AquaTech, Brookings, SD, USA), was
evaluated and reported to have comparable CP and AA digestibility relative to FM in
10kg pigs. Further, pigs fed a diet containing bioprocessed soybean meal had reduced
incidence and severity of after weaning diarrhea (Sinn et al., 2016). The impact of feed
stuffs on animal performance will continue to be important; however, advances in science
and technology are prompting nutritionists to look at more than just performance when
considering dietary inclusion of alternative ingredients in the diet. The immature
immune system of the weaned pig is attracting more attention as restrictions on
antibiotics use in livestock continue. Thus, the potential for dietary ingredients to boost
innate or adaptive immune response in weaned pigs is of great interest. The objective of
this experiment was to assess the effects of bioprocessed soybean meal alone or in
combination with SDP or FM in a corn and SBM based diet on immune response in
weaned pigs. We hypothesized that inclusion of bioprocessed soybean meal in nursery
pig diets could enhance innate and adaptive immune response of weaned pigs.

2.3 MATERIALS AND METHODS

All procedures used in this experiment were approved by the South Dakota State
University Institutional Animal Care and Use Committee (#15-114A). Pigs used for this
trial were the offspring of Landrace × Large White sows mated with Hampshire ×
German Large White boars and were obtained from a high health commercial piggery
(Claremont Hutterite Colony, Castlewood, SD, USA). Pigs were vaccinated against
mycoplasma and porcine circovirus (FLEXcombo, Boehringer Ingelheim Vetmedica Inc,
St. Joseph, MO, USA) prior to delivery.
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The bioprocessed soybean meal evaluated in this study was provided by Prairie
AquaTech and processed by incubating a pasteurized slurry of SBM and water with the
fungus Aureobasidium pullulans for 4 to 5 days. After incubation, the slurry is separated
by centrifugation and the solids are recovered and dried (Gibbons and Brown, 2016).
The bioprocessed soybean meal contains reduced trypsin inhibitor (68.88 TIU/g),
raffinose (0.00%), and stachyose (0.02%) compared to conventional SBM 2596 to 6090
TIU/g, 0.98%, and 3.07%, respectively (Choct et al., 2010; Sinn et al., 2016).
Animals, diets, and experimental design
A total of 239 pigs were weaned at 21 ± 1 d of age (initial BW 6.56 ± 0.87 kg)
into 48 pens (3 barrows and 3 gilts/pen; n = 10 pens/treatment) for a 35-d study. The
study was conducted in 2 blocks with 120 and 119 pigs in block 1 and 2, respectively.
When pigs arrived from the commercial piggery in the second block, there was 1 less pig
than expected; therefore, 1 pen in the second block contained 3 barrows and 2 gilts. Each
pen (1.8 x 1.3 m) provided a minimum of 0.36m2/pig and contained 1 nipple drinker and
a 3-hole self-feeder to provide ad libitum access to feed and water. At weaning, pigs
were randomly allotted to 1 of 4 dietary treatments: 1) Control (CON; corn, SBM and
whey based diet containing FM and SDP), 2) the CON with bioprocessed soybean meal
replacing FM (BPSBM+SDP), 3) the CON with bioprocessed soybean meal replacing SDP
(BPSBM+FM), and 4) the CON bioprocessed soybean meal replacing both FM and SDP
(BPSBM). Experimental diets were fed in a 2-phase feeding program where Phase I was
fed from 0 to 7 d and Phase II was fed from 8 to 21 d after weaning (Table 1). Phase III
consisted of a common corn/SBM diet for 22 to 35 d after weaning. All diets were fed in
a meal form and were formulated to meet or exceed NRC (2012) requirements for
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weaned pigs. Subsamples of each diet were collected weekly throughout the trial and
stored at -20°C for analysis.
Pigs were housed in an environmentally controlled room where the initial room
temperature was 28 ± 1°C and decreased at a rate of 1°C/wk. Animal care followed
South Dakota State University protocol including daily monitoring for signs of poor
health (i.e. huddling, diarrhea, anorexia, lethargy). When necessary, veterinary
intervention was applied [e.g. Excenel (Zoetis, Kalamazoo, MI) via i.m. injection at 1
mL/17 kg once daily for 3 d for diarrhea requiring antibiotic treatment]. Individual pigs
were removed when veterinary intervention was unsuccessful (i.e. BW loss or no BW
gain after d 21 on trial). Average daily gain, ADFI, and G:F were determined by
weighing pigs and measuring feed disappearance at 7-d intervals.
Antigen-specific immune response
At d 7 after weaning, 1 pig per pen was selected based on the mean weight of the
pen and sensitized with ovalbumin (OVA) and killed Candida albicans (CAA) to assess
antibody mediated-immune response and cell mediated-immune response as described by
Heriazon et al. (2009) with modifications (Fig. 1). Briefly, pigs were sensitized using 0.5
mg OVA, (Grade VII, Sigma-Aldrich, St. Louis, MO, USA), 0.5 mg CAA (CaWC, crude
whole cell, Greer Laboratories, Inc, Lenoir, NC, USA), and 0.5 mg of Quil A (Quillaja
saponin, Brenntag Biosector A/S, Denmark) in 1.0 mL of saline, via an i.m. injection on
d 7 (prime) and 21 (booster) after weaning with a 21-gauge needle. Blood was collected
into non-heparinized blood collection tubes (Becton, Dickinson and Company, Franklin
Lakes, NJ, USA) prior to sensitization on d 7 and 21, and again on d 28 to determine presensitization, primary, and secondary anti-OVA IgG as a measure of antibody mediated-
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immune response. A dermal sensitivity test against OVA and CAA was performed at 28
d after weaning to determine cell mediated-immune response. Pigs received 3 separate
100 µL intradermal injections on the belly; 1) saline, 2) OVA (4 mg/mL in saline), 3)
candin (4 mg/mL in saline; C. albicans purified protein extract, Greer Laboratories, Inc,
Lenoir, NC, USA). Skin thickness on the belly was measured using a skin-fold caliper
(Model RH15 9LB, Creative Health Products Inc, Ann Arbor, MI, USA) prior to
injection and at 2, 6, 24, and 48h after injection.
Anti-OVA IgG ELISA
Serum antibodies from blood samples taken on d 7, 21, or 28 were determined
using an anti-OVA IgG ELISA assay developed at SDSU. A 10 µL serum sample from
each pig of the negative control (d 7), primary (d 21), and secondary (d 28) time points
were pooled and the appropriate serum and conjugate dilutions were determined by
chessboard titration. Ninety-six well, high-affinity flat bottom polystyrene plates
(Corning Inc, Kennebunk, ME, USA) were coated with OVA dissolved in 1 mL
carbonate-bicarbonate buffer (pH 9.6) and incubated at 4°C for 24 h. Plates were then
washed (100 µL/well) with PBS and 0.05% Tween 20 (Sigma-Aldrich, St. Louis, MO,
USA; washing buffer, pH 7.4) 5 times and blocked with ELISA Ultrablock (200 µL/well;
Bio-Rad Laboratories, Inc, Hercules, CA, USA) at room temperature for 1 h and washed
again 5 times. Controls and samples were diluted 1/400 and 1/800 and incubated in
triplicates for 2 h at room temperature. Plates were washed 5 times and alkaline
phosphatase-conjugated rabbit anti-swine IgG (Sigma-Aldrich. St. Louis, MS, USA) was
diluted 1/8000 in wash buffer and incubated for 1 h at room temperature. After washing
the plates 5 times, p-nitrophenyl phosphate disodium (pNPP; Sigma-Aldrich. St. Louis,
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MS, USA) was added and incubated in the dark for 30 min at room temperature. Plates
were read on a Spectra MAX 190 plate reader (Molecular Devices, LLC, Sunnyvale, CA,
USA) at 405 nm wave length and the optical density (OD) values were obtained using
SoftMax Pro 6.2.1 Microplate Data Acquisition and Analysis Software (Molecular
Devices, LLC, Sunnyvale, CA, USA).
Peripheral blood mononuclear cell separation
At 14 d after weaning, a blood sample was collected into sterile vacutainer tubes
(Becton, Dickinson and Company, Franklin Lakes, NJ, USA) containing K2 EDTA from
1 pig/pen for peripheral blood mononuclear cell (PBMC) separation. Blood was diluted
with 15 mL of 1X PBS (pH 7.4) and then gently layered over 15 mL of Histopaque-1077
(Sigma-Aldrich, St. Louis, MO, USA) into a sterile 50 mL conical vial. Samples were
centrifuged at 800 × g for 30 min at room temperature with no brake. The PBMC layer
or “white buffy coat” was then carefully collected into a 15 mL conical vial, mixed with
2 mL of water to lyse red blood cell contamination and then brought to 15 mL with 1X
PBS (pH 7.4). Cells were centrifuged at 400 × g for 15 min at room temperature,
supernatant was poured off, and cells were re-suspended in 1X PBS (pH 7.4). This
process was repeated 5 times and after the 5th wash, cells were suspended in a cell culture
medium containing; RPMI-1640 (Sigma-Aldrich, St. Louis, MO, USA) with 10% fetal
bovine serum (Sigma-Aldrich, St. Louis, MO, USA), and 1% PenStrep (100 U/mL
penicillin and 100 µg/mL streptomycin; Sigma-Aldrich, St. Louis, MO, USA). Cells
were counted using Trypan blue (Fisher Scientific, Hampton, NH, USA) and a
hemocytometer and cells were diluted to 4x106 cells/mL for lymphocyte proliferation.
Lymphocyte proliferation
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Diluted PBMCs were plated on Corning Costar 96 well flat bottom high affinity
plates (Corning Inc, Kennebunk, ME, USA), at a concentration of 2x105 cells/mL for a
total volume of 100 µL, with 15 wells/sample. Cells were plated in 3 sets of
quintuplicate wells for each treatment 1) cells with no mitogens served as negative
control , 2) cells with phytohemagglutinin (PHA-P; 5 µg/mL, Sigma-Aldrich, St. Louis,
MO, USA), and 3) cells with Concanavalin A, (ConA; 5 µg/mL, Sigma-Aldrich, St.
Louis, MO, USA). Plates were incubated for 96 h at 37°C and 5% CO2. After 96 h a
Roche Applied Biosciences cell proliferation ELISA, BrdU kit (colorimetric; Cat# 11 647
229) was used according to manufacturer’s instructions to measure cell proliferation.
Statistical analysis
Data were analyzed using the PROC MIXED procedure of SAS (Version 9.3;
SAS Inst. Inc., Cary, NC). Pen was the experimental unit for the performance data, and
individual pig was the experimental unit for the antibody mediated-immune response, cell
mediated-immune response, and lymphocyte proliferation data. Assumption of
homogeneity of variances and normality were confirmed prior to analysis of variance
using the PROC GLM procedure in SAS. Least square means were calculated using the
LSMeans procedure in SAS and significant differences among treatments were separated
using PDIFF option with the Tukey adjustment for the performance data, antibody
mediated-immune response, and lymphocyte proliferation. Test results were considered
significant where P < 0.05 and tendency towards significance at 0.05 ≥ P ≤ 0.10.

2.4 RESULTS
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A total of 7 pigs were removed from block 1 and 7 pigs removed in block 2 for a
total removal of 4 from the CON group, 3 from the BPSBM+SDP group, 4 from the
BPSBM+FM group, and 3 from the BPSBM group for reasons described previously.
There was no difference in initial BW between treatments or by block (Table 2). Pigs fed
CON were heavier (P < 0.01) than pigs fed BPSBM+FM and BPSBM and not different
from pigs fed BPSBM+SDP at d 7 after weaning. Also, pigs fed BPSBM+SDP and BPSBM
were not different at d 7. Pigs fed CON remained heavier (P < 0.035) than pigs fed
BPSBM+FM at d 14 and 21 and tended (P = 0.068) to be heavier than pigs fed BPSBM+FM
at d 28. Pigs fed CON, BPSBM+SDP or BPSBM were not different at d 14, 21, or 28.
There was no difference in BW at d 35 between dietary treatment groups. In Phase I,
pigs fed CON had a greater (P = 0.005) ADG compared with pigs fed BPSBM+FM and
BPSBM but not different from pigs fed BPSBM+SDP and pigs fed BPSBM+SDP were not
different from BPSBM. Pigs fed CON tended to have greater (P = 0.091) ADG than pigs
fed BPSBM+FM, or were not different than pigs fed BPSBM+SDP or BPSBM at the end of
Phase II. There was no difference in ADG at the end of Phase III. There was no
difference in ADFI at the end of Phase I, II, and III. Similarly, there was no difference in
G:F at the end of Phase I and III. However, pigs fed BPSBM+SDP tended (P = 0.065) to
have a greater G:F than pigs fed BPSBM, and were not different from pigs fed CON or
BPSBM+FM at the end of Phase II. There was an effect of block, where initial weight was
not different between blocks and pigs in block 1 were heavier than block 2 at the end of
each phase (6.75 ± 0.18 and 6.36 ± 0.18 kg, respectively [P = 0.137], at the beginning;
7.16 ± 0.06 and 6.28 ± 0.06 kg, respectively [P < 0.001], in Phase I; 12.76 ± 0.15 and
11.21 ± 0.15 kg, respectively [P < 0.001] in Phase II; 22.06 ± 0.26 and 19.38 ± 0.27 kg,
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respectively [P < 0.001] in Phase III. Pigs in block 1 also had a greater ADG compared
with pigs in block 2 at the end of each phase (0.09 ± 0.01 and -0.03 ± 0.01 kg,
respectively [P < 0.001] in Phase I; 0.43 ± 0.01 and 0.35 ± 0.01 kg, respectively [P <
0.001] in Phase II; 0.67 ± 0.01 and 0.56 ± 0.01 kg, respectively [P < 0.001] in Phase III).
Similarly, pigs in block 1 had a greater ADFI compared with pigs in block 2 at the end of
each phase (0.15 ± 0.005 and 0.06 ± 0.005 kg, respectively [P < 0.001] in Phase I; 0.53 ±
0.01 and 0.45 ± 0.01 kg, respectively [P < 0.001] in Phase II; 0.98 ± 0.01 and 0.88 ± 0.03
kg, respectively [P = 0.007] in Phase III). The effect of block on G:F followed a similar
pattern (data not shown). However, there was no difference in the pattern of response to
diet.
Immune response
There were no differences between pigs fed CON, BPSBM+SDP, BPSBM+FM, or
BPSBM in the dermal hypersensitivity response to OVA at 0, 2, 6, 24, or 48 h after
injection. The hypersensitivity response to OVA peaked (P < 0.001) at 2 h after injection
in pigs fed CON, BPSBM+SDP, and BPSBM+FM but at 6 h after injection in pigs fed
BPSBM (Fig. 2A). There were no differences in swelling from 6 to 24 h in pigs fed
CON, BPSBM+SDP, and BPSBM+FM, but pigs fed BPSBM tended (P = 0.053) to have a
greater swelling at 6 h compared with 24h after injection. There were no differences in
swelling after injection regardless of dietary treatment. The hypersensitivity response to
candin peaked (P < 0.01) at 2 h after injection in pigs fed CON, BPSBM+SDP,
BPSBM+FM, and BPSBM (Fig. 2B). There were no differences in swelling from 6 to 24 h
in pigs fed CON, BPSBM+SDP, and BPSBM+FM, but pigs fed BPSBM had greater (P =
0.038) swelling at 6 h compared with 24h after injection. There were no differences
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between pigs fed CON, BPSBM+SDP, BPSBM+FM, or BPSBM. Pigs in block 2 had a
greater response to OVA at 2 h after injection than pigs in block 1 (132.9 ± 9.25 and 96.8
± 9.04%, P = 0.007, respectively). Similarly, pigs in block 2 tended to have a greater
response to candin at 2 h after injection than pigs in block 1 (51.6 ± 8.25 and 33.0 ±
4.80%, P = 0.057, respectively). At 6 h after injection pigs in block 2 also had a
prolonged response to candin compared with pigs in block 1 (31.6 ± 4.51 and 15.6 ±
4.82%, P = 0.017, respectively). There was no significant treatment × block interaction.
Anti-OVA IgG at 21 and 28 d after sensitization were higher (P = 0.051 and P <
0.001, respectively) compared with d 0 indicating a primary and secondary response antiOVA IgG response (Fig. 3). There was no effect of dietary treatment on anti-OVA IgG;
however, the 21-d time point is the mean of 5 observations/dietary treatment, rather than
10 due to an error during blood collections in block 1.
Proliferation of PBMCs in response to mitogenic stimulation with PHA-P and
ConA was greater than the negative control [(1.15 and 2.14 vs. 0.22, pooled SEM 0.08,
optical density at 370 nm [OD370nm; P = 0.001], respectively, where the negative
control had no mitogenic stimulation)] confirming the biological effects of PHA-P and
ConA at the concentrations used in this study (Fig. 4). Values are based on optical
density readings from ELISA assay. There were significant differences between blocks
where proliferative response in peripheral blood lymphocytes from pigs in block 2
exposed to PHA-P and ConA had greater than that from pigs in block 1 (1.93 and 2.91 vs.
0.37 and 1.37, pooled SEM 0.11 OD370nm, respectively; P < 0.001). There were no
differences between block 1 and 2 for negative control cells (0.23 vs 0.22, pooled SEM
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0.11 OD370nm, respectively; P = 0.192). No difference in proliferation among dietary
treatment were detected.

2.5 DISCUSSION

Anti-nutritional factors in SBM may be detrimental for newly weaned pigs.
Further processing of SBM can significantly reduce the levels of anti-nutritional factors
and allow these processed SBM products to be used in weaned pig diets (Min et al., 2004;
Sinn et al., 2016) at higher levels with minimal negative impact on growth performance.
The aim of this study was to assess nursery pig growth performance and immune
response to bioprocessed soybean meal alone or in combination with SDP or FM in early
wean diets. We hypothesized that inclusion of bioprocessed soybean meal in nursery pig
diets could enhance innate and adaptive immune response of weaned pigs. By the end of
Phase III there was no differences in BW among dietary treatment groups despite slower
growth in the first 7 d after weaning confirming that bioprocessed soybean meal could
replace SDP or FM with little long-term impact on pig performance. Feed intake during
the first week after weaning is typically a challenge and therefore many studies often start
at 7 d after weaning in an attempt to minimize the effects of weaning and focus on the
dietary effects. Jones et al. (2010) observed a similar reduced performance in the early
after weaning period in pigs fed diets containing the combination of FM and fermented
SBM compared with pigs fed a combination of dried porcine solubles and fermented
SBM.
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Zhou et al. (2011) reported that feeding enzymatically converted SBM increased
the percentage of T lymphocytes, CD4+ and CD8+ cells in peripheral blood of weaned
pigs compared with a corn/soy diet. This increase in T lymphocytes is beneficial to a
young pig that is heavily reliant on its innate immune system as the primary defense
against pathogens. The boost in cellular immunity from an enzymatically converted
SBM would suggest that it is reasonable to expect a similar product such as bioprocessed
soybean meal to have an impact on immune response. The prolonged hypersensitivity
response to OVA in pigs fed BPSBM would indicate an enhanced T cell recruitment
which would benefit a piglet facing an immune challenge. Further, evidence of
phytoestrogens and other soy isoflavones found in SBM have been shown to provide
immunological benefits (Greiner et al., 2001; Patisaul and Jefferson, 2010) and the
presence of estrogen receptors within the gastrointestinal tract (Campbell-Thompson et
al., 2001) may positively impact the gut by favoring cell proliferation and digestive
function. The removal of antinutritional factors during processing of the soybean meal
helps improve digestive function and may provide immunological benefits. To
investigate antigen-specific immune response dermal hypersensitivity was measured as
an estimate of T cell recruitment to the site of inflammation and as an indicator of cell
mediated-immune response. The hypersensitivity response to OVA and CAA are Thelper type 2 and T-helper type 1 responses representing immediate and delayed-type
hypersensitivity response, respectively. The peak response to CAA at 2 h in this study
differed from the response to CAA reported in cattle and sheep where delayed
hypersensitivity (T-helper type 1, i.e. peak at 24 to 72 h) was reported (You et al., 2008;
Heriazon et al., 2009). It is unclear why dermal response in this study peaked at 2 h after
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injection rather than 24 to 48 h after injection; however, Kabe et al. (1971) reported an
immediate response to aerosol polysaccharide fraction inhalation from CAA in guinea
pigs as well as a delayed response 24 h after exposure. Although there was a prolonged
response in pigs fed 3 of the experimental diets, peak swelling still clearly occurred at 2 h
after injection. The present data indicate that CAA may elicit dual reactions of both
immediate and delayed response and therefore an alternative antigen such as
Mycobacterium tuberculosis may be needed to elicit a delayed type dermal
hypersensitivity response in pigs.
While the difference in anti-OVA IgG was not significant it is important to note
the low number of replicates and potential when more replicates are added. An increase
in circulating antibodies would be beneficial by potentially allowing the pig to clear an
infection faster and more efficiently thus improving health. This enhancement of the
antibody mediated-immune response will need to be evaluated using a practically
relevant antigen/vaccination before definite conclusions can be made.
Phytohemagglutinin and ConA are T cell mitogens used to stimulate proliferation
in cell culture assays as a measurement of non-specific cell mediated-immune response.
Dietary protein source did not influence PBMC proliferation from mitogenic stimulated
cells and negative control cells. The greater proliferation from mitogenic stimulation in
block 2, in combination with the lower performance compared with pigs in block 1,
indicate that pigs in block 2 were likely experiencing a subclinical challenge. However,
response to diets were not different. This is important because it is often argued that
University run trials are performed in very clean, low stress environments and may not be
representative of what would be observed in the field. The proposed subclinical health
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challenge that pigs in block 2 underwent would be more representative of a commercial
environment. Although this was not the intention the results are valuable and support the
hypothesis that bioprocessed soybean meal can replace both SDP and FM in nursery pig
diets. Additional evaluation of the potential for enhanced antibody production with the
inclusion of bioprocessed soybean meal following industry relevant vaccination is
warranted.
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Table 2. 1 Ingredient composition and nutrient content of control and experimental diets fed to weaned pigs, as fed basis1
Phase I
Item
Ingredient (%)
Corn
BPSBM2
Whey, dried
Soya oil
Select Menhaden
fishmeal
Blood plasma3
Soybean meal,
dehulled (46.5%)
L-Lys-HCl
DL-Met
L-Thr
L-Trp
Limestone
Salt
Monocalcium
phosphate
Vitamin premix4
Mineral premix5
Zinc oxide
Formulated content
Total Lys %
SID Lys %
Met + Cys:Lys
ratio, %
Thr:Lys ratio, %
Ile:Lys ratio, %
Val:Lys ratio, %
Trp:Lys ratio, %

Phase II

CON

BPSBM+SDP

BPSBM+FM

BPSBM

CON

BPSBM+SDP

BPSBM+FM

BPSBM

Phase
III

42.65
25.00
1.25

41.07
7.50
25.00
1.45

37.57
12.00
25.00
1.00

34.40
20.00
25.00
3.40

56.40
10.00
1.00

54.93
5.00
10.00
1.50

51.31
8.00
10.00
1.40

48.02
15.00
10.00
1.80

61.21
2.10

7.50
6.50

6.50

7.50
-

-

5.00
3.00

3.00

5.00
-

-

-

15.00
0.05
0.19
0.70
0.25

15.00
0.33
0.19
0.03
0.03
1.20
0.25

15.00
0.04
0.14
0.60
0.25

15.00
0.33
0.17
0.08
0.07
1.10
0.25

22.00
0.18
0.17
1.00
0.25

22.00
0.37
0.15
0.07
0.03
1.20
0.25

22.00
0.09
0.10
0.85
0.25

22.00
0.21
0.10
0.02
1.20
0.25

33.00
0.50
0.13
0.18
0.03
1.20
0.25

0.30
0.05
0.15
0.40

0.85
0.05
0.15
0.40

0.30
0.05
0.15
0.40

1.00
0.05
0.15
0.40

0.60
0.05
0.15
0.20

1.10
0.05
0.15
0.20

0.60
0.05
0.15
0.20

1.00
0.05
0.15
0.20

1.20
0.05
0.15
-

1.78
1.58

1.72
1.56

1.76
1.55

1.72
1.55

1.55
1.37

1.51
1.36

1.56
1.37

1.53
1.36

1.46
1.31

0.97
1.01
1.10
1.15
0.33

0.86
0.93
1.12
1.04
0.31

0.91
0.98
0.97
1.15
0.31

0.83
0.95
1.01
1.03
0.32

0.85
0.81
0.87
0.95
0.27

0.75
0.80
0.89
0.87
0.26

0.80
0.84
0.88
1.00
0.27

0.75
0.80
0.94
0.97
0.26

0.68
0.80
0.71
0.73
0.23
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Digestible energy
(kcal/kg)
3614
3573
3559
3559
3541
3533
3549
3537
3540
Lysine: digestible
energy (g/Mcal)
4.91
4.17
3.93
3.15
4.38
3.86
3.72
3.07
4.12
Analyzed
composition (%)
Dry matter
91.89
91.70
91.85
92.98
91.13
91.00
90.78
92.03
88.77
CP
22.16
23.33
25.80
25.98
23.93
21.28
22.16
25.88
21.36
Ash
6.88
6.67
6.24
6.47
6.20
5.67
6.11
6.12
5.22
Crude fat
3.73
3.72
4.31
3.64
4.13
3.65
4.06
3.59
2.87
Crude fiber
1.42
2.05
2.01
2.64
1.96
2.07
2.51
3.52
2.52
Lys
1.88
1.58
1.53
1.45
1.42
1.46
1.80
1.95
1.89
1
Experimental diets were fed from d 0 to 7 (Phase I) and from d 8 to 21 (Phase II) after weaning. All pigs received a common Phase
III diet from d 22 to 35.
2

BPSBM+SDP = the CON with bioprocessed soybean meal replacing fish meal.

3

BPSBM+FM = the CON with bioprocessed soybean meal replacing spray-dried plasma.

4

BPSBM = the CON with bioprocessed soybean meal replacing both fish meal and spray-dried plasma

6

Appetein (APC, Ankeny, IA, USA).

7

Provided per kg of complete diet: 11,002 IU vitamin A supplement, 1651 IU vitamin D3 supplement, 55.1 IU vitamin E supplement,

0.044 mg vitamin B12 supplement, 4.4 mg menadione as menadione dimethylpyrimidinol bisulfite, 9.91 mg riboflavin supplement,
60.6 mg D-pantohenic acid as D-calcium, 55.1 mg niacin supplement, 1.1 mg folic acid, 3.3 mg pyridoxine as pyridoxine
hydrochloride, 3.3 mg thiamine as thiamine mononitrate and 0.171 mg biotin.
8

Provided per kg of the complete diet: 165 mg Zn as zinc sulfate, 165 mg Fe as ferrous sulfate, 43.5 mg Mn as manganese sulfate, 16.5

mg Cu as basic copper chloride, 0.36 mg I as ethylenediamine dihydriodide and 0.3 mg of Se as sodium selenite.
9

SID = standardized ileal digestibility
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Table 2. 2 Effect of dietary inclusion of bio-processed SBM alone or in combination
with fish meal (FM) and spray dried plasma (SDP) on growth performance of weaned
pigs1
Item
BW, kg
d0
d7
d 14
d 21
d 28
d 35
ADG, kg/d
Phase I
Phase II
Phase III
ADFI, kg/d
Phase I
Phase II
Phase III
G:F
Phase I
Phase II
Phase III

CON

BPSBM+SDP

BPSBM+FM

BPSBM

SEM

P-value

6.69
6.99a
8.74a
12.47a
16.27x
21.00

6.52
6.80a,b,x
8.47a,b
12.18a,x
16.08x,y
20.70

6.52
6.52c,y
7.74b
11.42b,y
15.12y
20.28

6.51
6.60b,c
8.19a,b
11.85a,b
15.86x,y
20.89

0.26
0.08
0.24
0.21
0.31
0.37

0.949
0.001
0.035
0.011
0.068
0.554

0.06a
0.41x
0.60

0.04a,b
0.40x,y
0.59

0.02b
0.36y
0.62

0.01b
0.39x,y
0.64

0.01
0.02
0.02

0.005
0.091
0.168

0.12
0.50
0.92

0.11
0.49
0.92

0.10
0.46
0.94

0.11
0.51
0.95

0.01
0.02
0.03

0.129
0.139
0.843

0.27
0.80a,b
0.66

0.02
0.83a
0.64

-0.16
0.80a,b
0.67

-0.19
0.77b
0.68

0.16
0.02
0.02

0.170
0.065
0.717

Within rows, mean values with unlike superscript a,b,c and x,y differed at (P < 0.05 and P <
0.1, respectively).
1

A total of 239 pigs (initial BW 6.56 ± 0.87 kg) in 48 pens (3 barrows and 3 gilts/pen; n = 10

pens/treatment) were used in a 35-d study. Experimental diets were fed from d 0 to 7 (Phase
I) and d 8 to 21 (Phase II) after weaning. All pigs received a common Phase III diet from d
22 to 35. The CON was a corn, soybean meal, whey (25%), FM (7.5%), and SDP (6.5%)
based diet with decreasing inclusion of whey (10%), FM (5%), and SDP (3%) from Phase I to
Phase II, respectively. BPSBM+SDP = the CON with BPSBM replacing FM (7.5 and 5% in
Phase I and II, respectively). BPSBM+FM = the CON with BPSBM replacing SDP (12 and
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8% in Phase I and Phase II, respectively). BPSBM = CON with BPSBM replacing both FM
and SDP (20 and 15% in Phase I and Phase II, respectively).
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Figure 2. 1

Timeline of sensitization to ovalbumin (OVA) and Candida albicans (CAA), dermal
hypersensitivity test and collection of peripheral blood mononuclear cells for lymphocyte
proliferation. Pigs were weaned at 21 ± 1 d of age. Experimental diets were fed in Phase
I and II, and a common nursery diet was fed in Phase III
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Figure 2. 2

Dermal hypersensitivity to ovalbumin (OVA; Sigma-Aldrich, St. Louis, MO; A)
and candin (Greer Laboratories, Inc., Lenoir, NC; B) on the belly of pigs fed diets
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containing fish meal (FM), spray-dried plasma (SDP), bioprocessed soybean meal or
their combination. Pigs were given an intramuscular injection (0.5 mg Quil A [Brenntag
Biosector A/S, Frederikssund, Denmark], 0.5 mg OVA and 0.5 mg killed C. albicans in 1
mL saline) at d 7 and 21 and a dermal hypersensitivity test was conducted on d 28. Pigs
received 3 intradermal injections; 1) saline (100 µL), 2) OVA (4 mg OVA/mL in 100
µL), and 3) candin (4 mg/mL; C. albicans purified protein extract in 100 µL) on the belly
and skin fold thickness was measured at 0, 2, 6, 24, and 48 h after injection. The percent
increase in skin thickness over baseline were calculated. Data represents least square
means and SEM of 10 pigs/dietary treatment.

a,b

Within dietary treatment, timepoints

with different superscripts differ (P < 0.05) x,yWithin dietary treatment, time points with
different superscripts differ (P < 0.1). CON = control; BPSBM+SDP = the CON with
bioprocessed soybean meal replacing FM; BPSBM+FM = the CON with bioprocessed
soybean meal replacing SDP; BPSBM = the CON with bioprocessed soybean meal
replacing both FM and SDP.
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Figure 2. 3

Anti-ovalbumin (OVA) IgG in pigs fed diets containing fishmeal (FM), spray-dried
plasma (SDP), bioprocessed soybean meal, or their combination. The control (CON)
diets contained FM and SDP. Pigs were intramuscularly injected with 0.5 mg Quil A
(Brenntag Biosector A/S, Frederikssund, Denmark), 0.5 mg OVA (Sigma-Aldrich, St.
Louis, MOS), and 0.5 mg killed C. albicans in 1 mL of saline at d 7 and 21, representing
the prime and booster does. Serum was collected at 7, 21, and 28 d for determination of
pre- sensitization, primary, and secondary anti-OVA IgG. Data represents least square
means and SEM of 10 pigs/dietary treatment at d 7 and 21, and 5 pigs/dietary treatments
at d 28. BPSBM+SDP = the CON with bioprocessed soybean meal replacing FM;
BPSBM+FM = the CON with bioprocessed soybean meal replacing SDP; BPSBM = the
CON with bioprocessed soybean meal replacing both FM and SDP.
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Figure 2. 4

Lymphocyte proliferation in pigs fed diets containing fishmeal (FM), spray dried
plasma (SDP), bioprocessed soybean meal, or their combination. The control (CON)
diets contained FM and SDP. Proliferation response to phytohemagglutinin (PHA-P) and
Concanavalin A (ConA) was determined on d 14 after weaning. Data represents least
square means and SEM of 10 pigs/dietary treatment. BPSBM+SDP = the CON with
bioprocessed soybean meal replacing FM; BPSBM+FM = the CON with bioprocessed
soybean meal replacing SDP; BPSBM = the CON with bioprocessed soybean meal
replacing both FM and SDP; NEG = cells with no mitogenic stimulation.
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3.0 Evaluation of a bio-processed soybean meal on nursery pig immunological
resistance to PRRSV1
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3.1 ABSTRACT
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We investigated the effects of fish meal (FM), and spray dried plasma (SDP) in
combination with a bio-processed soybean meal (BPSBM) on immunological resistance
to porcine reproductive and respiratory syndrome virus (PRRSV) and antibody titer to a
commercial porcine circovirus swine vaccine. A total of 72 barrows (initial BW 6.68 ±
0.15 kg, 21 d of age) were used in a 21-d study (-7 to 14 d post-inoculation, DPI) with 48
PRRSV infected (POS) and 24 uninfected (MOCK) pigs. All pigs were housed in
individual pens (12 pens/room). The POS and MOCK pigs were housed in separate
buildings and no staff transfer occurred between buildings. Infected pigs were randomly
allotted to one of 4 dietary treatments: positive control diet containing 1) SDP and FM
(CON), 2) SDP and BPSBM (BPSBM+SDP), 3) FM and BPSBM (BPSBM+FM), or 4)
BPSBM alone. The MOCK pigs were fed the CON or BPSBM diet. On -7 days postinoculation (DPI), MOCK pigs were vaccinated with a commercial porcine circovirus
(PCV2) vaccine for determination of PCV2 neutralizing antibodies. On 0 DPI, MOCK
pigs received 1 mL of minimal essential media and POS pigs received a 1 x 105 50%
tissue culture infective dose of PRRSV (NADC20) diluted in 1 mL of minimal essential
media. Feed disappearance was measured weekly. Body weight and rectal temperature
were measured, and a blood sample was collected on 0, 3, 7, 10 and 14 DPI. At 14 DPI,
all pigs were euthanized and the lungs were removed for gross and microscopic lesion
scoring. Daily gain was greater (P=0.039) in POS pigs compared to MOCK pigs prior to
inoculation and lower (P=0.024) from 0 to 7 DPI. The MOCK pigs had negative serum
PRRSV titers at all timepoints while POS pigs had positive serum PRRSV titers at 3, 7,
10, and 14 DPI. The POS pigs had higher rectal temperatures at 3 DPI (39.5 vs. 38.9 ±
0.09 °C, P < 0.001). Dietary treatment did not impact growth performance or serum
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PRRSV load at any time point. A greater proportion (P<0.05) of MOCK pigs fed
BPSBM had high levels of circulating PCV2 neutralizing antibodies at 7 and 14 DPI
compared to CON-fed pigs. While inclusion of BPSBM in early weaned diets did not
appear to influence the response to PRRSV, the positive impact of BPSBM on adaptive
immune response indicates potential improved immunological functions.
Keywords: bio-processed soybean meal, weaned pig, immune challenge, PRRSV

3.2 INTRODUCTION

In 1987 the USA experienced a new disease in swine that caused late-term
reproductive failure and severe pneumonia in neonatal pigs. It became referred to as
porcine reproductive and respiratory syndrome virus (PRRSV), a single stranded,
enveloped RNA virus in the family Arteriviridae. PRRSV infection in weaned pigs is
characterized by fever, pneumonia, and lethargy. Secondary bacterial infections often
persist and lead to an increased mortality and sometimes complicate the PRRSV clinical
representation (Rossow, 1998). Today, PRRSV is one of the most important diseases of
swine causing devastating economic losses to the USA swine industry, with an estimated
annual loss of $664 million (Holtkamp et al., 2012). However, despite current
vaccination programs and genetic selection for pig’s resistant to the virus, PRRSV
continues to pose a significant economic burden to producers in the USA and around the
world and nutritional strategies to alleviate the syndrome should be financially beneficial.
Little research has been conducted on the effects of ingredients in mitigating viral
infections. However, isoflavones from soy have been demonstrated to influence virus
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infectivity (Andres et al., 2009). Soybean meal (SBM) which contains isoflavones was
fed at high concentrations (29%) in nursery diets and was reported to modulate the
immune response and also improve growth performance compared to nursery pigs fed a
lower concentration (17%) of SBM (Rochell et al., 2015). Further processing of SBM
may have positive impacts on immune response and growth performance when pigs are
challenged with PRRSV. Additionally, little research has been done on specialty amino
acid sources such as bio-processed soybean meal (BPSBM) or others commonly included
in nursery diets; including spray-dried plasma (SDP) or fishmeal (FM). Therefore, the
purpose of this experiment was to assess the effects of BPSBM alone or in combination
with SDP or FM on nursery pig’s immunological response to a PRRSV challenge. We
hypothesized that the inclusion of BPSBM in nursery pig diets would enhance immune
response to a PRRSV challenge and adaptive immune response to a commercial porcine
circovirus vaccine.

3.3 MATERIALS AND METHODS

All procedures used in this experiment were approved by the South Dakota State
University Institutional Animal Care and Use Committee (#16-093A). Pigs used for this
trial were the offspring of Camborough sows mated with PIC line 359 sire and were
obtained from a commercial piggery (Mustang Pass, Aurora, SD, USA).
2.1 Animals and experimental design
A total of 72 weanling barrows (21 ± 1 d of age; initial BW 6.68 ± 0.15 kg), in 2
equal blocks, were assigned to a PRRSV challenge group (POS, n = 48) and an
uninfected group (MOCK, n = 24). The POS group were individually housed in a bio-
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secure disease containment facility at the South Dakota State University Veterinary
Animal Resource Wing which consisted of two rooms, each equipped with a highefficiency particulate air filtration system and divided into 12 individual pens (0.56 m2)
with tenderfoot flooring. Each pen contained 1 nipple drinker and a 3-hole self-feeder to
provide ad libitum access to feed and water. Lighting was provided on a 12-h cycle and
temperature was held at 28 ± 1°C and decreased at a rate of 1°C/wk. The MOCK group
were housed in the SDSU Animal Research Wing of the Animal Science building in
individual pens (0.56 m2) equipped with tenderfoot flooring, 1 nipple drinker, a 1-hole
feeder with feed added twice a day as needed to provide ad libitum access to feed and
water. For each block, the study was conducted over 21 d (-7 to 14 d post-inoculation,
DPI) where pigs were adapted to experimental diets for 7 d prior to inoculation (-7 to 0
DPI). At 0 DPI, MOCK pigs received a 1 mL intramuscular injection of minimal
essential culture media and POS pigs received a 1 x 105 tissue culture infectious dose 50
(TCID50) of PRRSV strain (NADC20) diluted in 1 mL of culture media. Prior to entering
the disease containment chambers all personnel were required to shower and change into
protective clothing. Upon exiting all personnel were required to remove protective
clothing and shower out. Access to MOCK pigs from personnel working with POS pigs
was restricted.
2.2 Diets
At weaning, pigs were randomly allotted to one of 4 dietary treatments: 1) Control
(CON; corn, soybean meal and whey based diet containing fishmeal and spray dried
plasma), 2) control with BPSBM replacing FM (BPSBM+SDP), 3) control with BPSBM
replacing SDP (BPSBM+FM), and 4) control with BPSBM replacing both FM and SDP
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(BPSBM). Experimental diets were fed in a two-phase feeding program where Phase I
was fed from -7 to 0 DPI and Phase II was fed from 1 to 14 DPI (Table 1). All diets were
fed in a meal form and were formulated to meet or exceed NRC (2012) requirements for
weaned pigs. Subsamples of each diet were collected weekly throughout the trial and
stored at -20°C for analysis.
2.3 Growth, temperature, and tissue collections
Pigs were weighed on -7 DPI; weights and rectal temperatures were measured and
blood samples (5 mL) were collected on 0, 3, 7, 10, and 14 DPI. Blood was collected
into non-heparinized blood collection tubes (Becton, Dickinson and Company, Franklin
Lakes, NJ, USA) and submitted to the Animal Disease Research and Diagnostic
Laboratory for virological examination as described below. Feed weigh back was
recorded weekly and used to calculate ADG, ADFI, and G:F. At 14 DPI all pigs were
transported to the SDSU Animal Disease Research and Diagnostic Laboratory and
euthanized with a pentobarbital overdose (2-3 mL intracardiac injection, Euthanasia III
solution, Med-Pharmex Inc., Pomona, CA, USA). The lungs were removed and gross
visual scoring was performed immediately on each lobe by a trained pathologist. Tissue
samples were collected and placed into 10% neutral buffered formalin for slide
preparation and microscopic lesion scoring as described below.
Animal care followed SDSU protocol including daily monitoring for signs of poor
health (i.e. huddling, diarrhea, anorexia, lethargy). When necessary, veterinary
intervention was applied for humane care [e.g. Excenel (Zoetis, Kalamazoo, MI) via i.m.
injection at 1 mL/17 kg once daily for 3 days for diarrhea requiring antibiotic treatment].
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Individual pigs were removed when veterinary intervention was unsuccessful (i.e. BW
loss or no BW gain after d 21 on trial).
2.4 Viremia levels post-PRRSV infection
The levels of PRRSV viremia were assessed in serum. Serum samples were
processed at the SDSU Animal Disease Research and Diagnostic Laboratory. Serum was
separated by centrifugation, aliquoted, and stored at -80°C until use. Viral titration in
serum sample was performed in Marc145 cell line between passages 30 and 32. Cell
lines were grown in culture media (Corning Inc, Manassas, VA, USA), supplemented
with L-glutamine (1.4 mM, Corning Inc, Manassas, VA, USA), PenStrep (100 U/mL
penicillin and 100 µg/mL streptomycin; Gibco – Life Technologies, Rockford, IL, USA),
and 10% fetal bovine serum (FBS, Hyclone GE Healthcare Life Science, Logan, UT,
USA). Briefly, log10 serial dilutions were made with samples in culture media and four
replicates of each dilution were inoculated in 96 well plates (Corning Inc, Kennebunk,
ME, USA) and incubated for 48 h at 37°C and 5% CO2. Cells were then fixed in 3.7%
formaldehyde for 20 min and permeablizied with Triton X-100 0.01% (Sigma-Aldrich,
St. Louis, MO, USA) for 20 min and indirect fluorescent antibody technique was
performed. The primary antibody (SOW17) was added and incubated for 1 h at 37°C
followed by the secondary antibody (Alexa Flour 488 goat anti-mouse, Life
Technologies, Eugene, OR, USA) for 1 h at 37°C. Titers were calculated using the
Spearmann-Karber method and expressed as TCID50 per ml (Finney, 1964).
2.5 Gross and microscopic pathology
All pathology scoring was completed by a trained pathologist according to
methods described by Halbur et al. (1995; 1996) . Briefly, lungs were visually examined
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and an overall estimated percentage of the lung with visible pneumonia was recorded for
each pig. Each lobe was assigned a score to reflect the percentage of the entire lung
represented by that lobe. Ten possible points were assigned to each lobe (right cranial,
right middle, right caudal, left cranial and caudal of the cranial lobe, and left caudal). The
accessory lobe was assigned 5 points. The right and left caudal lobes were each assigned
27.5 points to reach a total of 100 points representing the entire (100%) lung. Gross lung
lesion scores were estimated, and a score was given to reflect the amount of pneumonia
presented in each lobe. The sum total for all the lobes was an estimate of the percentage
of the entire lung with visible gross pneumonia. For microscopic evaluation, a sample
from each lobe was fixed in 10% neutral buffered formalin, thin-sectioned at 5 µm, and
then stained with hematoxylin and eosin. Lung sections were then examined
microscopically and given an estimated score of the severity of interstitial pneumonia as:
0 = no microscopic lesions; 1 = mild interstitial pneumonia; 2 = moderate multifocal
interstitial pneumonia as follows; 3 = moderate diffuse interstitial pneumonia; 4 = severe
interstitial pneumonia.
2.7 Behavior and respiratory observations
Daily behavior and respiratory observations for all pigs began on 0 DPI and ended
on 14 DPI. Behavior was assessed on a numerical scale: 0 = normal behavior; 1 =
depressed; 2 = lethargic; and 3 = immobile/recumbent. Similarly, respiratory signs were
assessed on a numerical scale: 0 = normal; 1 = nasal discharge; 2 = sneezing; and 3 =
coughing. Respiratory rate was rated as: 0 = normal; 1 = difficult or rapid breathing; 2 =
abdominal breathing; and 3 = gasping.
2.8 PCV2 neutralizing antibodies
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On -7 DPI all MOCK pigs were vaccinated against porcine circovirus type 2
(PCV2) with CircoFLEX (Boehringer Ingelheim Vetmedica Inc, St. Joseph, MO, USA)
for determination of PCV2 neutralizing antibodies. Blood was collected on 7 and 14
DPI. Samples were then separated by centrifugation at 1,200 × g at room temperature.
Serum was frozen at -20°C and sent to Iowa State University Veterinary Diagnostic
Laboratory for PCV2 Fluorescent Focus Neutralization analysis.
2.9 Statistical analysis
Performance, PRRSV titer, and rectal temperature data were analyzed using the
PROC MIXED procedure of SAS (Version 9.3; SAS Inst. Inc., Cary, NC) where pig was
used as the experimental unit and pig nested within block was the random variable.
Gross and microscopic lung lesion scores and PCV2 neutralizing antibody data were
analyzed using a Chi-squared procedure in SAS. Assumption of homogeneity of
variances and normality were confirmed using the PROC GLM procedure in SAS prior to
analysis of variance. Least square means were calculated using the LSMeans procedure
in SAS. For data from infected pigs, differences between dietary treatments were
separated using PDIFF option with Tukey adjustment where main effects were
significant. Fisher’s Exact Test was used to test for significance on gross and
microscopic pathology and PCV2 neutralizing antibodies. Test results were considered
significant where P < 0.05 and tendency towards significance at 0.05 ≥ P ≤ 0.10.

3.4 RESULTS AND DISCUSSION

One pig was removed from the MOCK group in block 2 for feed refusal and
consistent weight loss. Following initial allocation to treatment, POS pigs were heavier
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(P = 0.026) at -7 DPI and tended to remain heavier (P = 0.065) at 0 DPI primarily due to
greater ADG (P = 0.039) in the first week (Table 2). In the first 7d following the PRRSV
inoculation, POS pigs had a lower (P = 0.024) ADG and similar ADFI resulting in a
tendency for reduced (P = 0.059) G:F. From 7 to 14 DPI there were no differences in
ADG, ADFI, or G:F and no difference in final BW between POS and MOCK pigs. There
were no differences in ADG, ADFI, or G:F between dietary treatments for POS pigs. No
viremia was detected in the MOCK pigs during the course of the study (data not shown).
The POS pigs were PRRSV negative at 0 DPI and positive at 3, 7, 10, and 14 DPI where
titers peaked (P < 0.001) between 7 and 10 DPI with no apparent dietary treatment effect
at any timepoint (Fig. 1). Rectal temperatures were higher in POS pigs compared to
MOCK pigs at 3 DPI and tended to be higher at 10 DPI (Fig. 2). There was no impact of
dietary treatment on rectal temperatures at any timepoint in POS or MOCK pigs (data not
shown).
The successful PRRSV infection, verified by high viral titers in the serum up to
10 DPI and reduced gain of POS pigs in the first 7 DPI demonstrate that the PRRSV
inoculation resulted in, at minimum, mild PRRSV infection. The decline in PRRSV titers
by 14 DPI correlates with previous reports of peak PRRSV viremia within the first 10
DPI (Greiner et al., 2001; Liu et al., 2013) and supports subclinical rather than clinical
infection level. It should be noted that reduced performance of MOCK pigs during the
adaptation period was potentially related to the additional stress of individual housing
rather than treatment designation. While both groups of pigs were individually housed
the ‘contamination’ rooms allowed the POS pigs visibility of 4-6 of their neighbors
compared to only 1 neighbor in the MOCK rooms. The reduced visibility of pigs in the
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MOCK room appeared to result in greater initial weaning-related stress; however, after
adapting to their new environment the pigs showed compensatory gain. Similar growth
performance of pigs fed BPSBM alone or in combination with SDP or FM was
previously reported in group-housed weaned pigs (Sinn et al., 2016; Koepke et al., 2017)
and further supports the conclusion that BPSBM is a suitable replacement for both FM
and SDP.
The primary objective of this study was to examine the impact of AA sources on
weaned pig’s response to PRRSV infection. There was no difference in the distribution
of gross lesion scores between dietary treatments and for all treatment groups greater than
75% of the pigs had low gross pneumonia scores (Fig. 3A). There was a difference (P =
0.013) in microscopic lesion scores where CON fed pigs had a higher proportion of
animals with low (0.1-1.0) microscopic lesion compared to BPSBM+SDP, BPSBM+FM, and
BPSBM fed pigs. Pigs fed BPSBM+SDP had the highest proportion of animals with
moderate (1.1-2.0) scores and BPSBM fed pigs had the highest proportion of animals
with high (2.1-3.0) scores. No pigs were found to have severe (3.1-4.0) microscopic
lesion scores (Fig. 3B). Crenshaw et al. (2017) reported that pigs fed spray-dried bovine
plasma had improved ADG, ADFI, and reduced mortality compared to pigs fed
alternative proteins including soy protein concentrate, poultry, egg, and fish protein.
Although no effect of dietary treatment was observed in gross percent pneumonia of POS
pigs; the greater proportion of CON and BPSBM+SDP fed pigs with low and moderate
microscopic lung lesion scores may indicate some protection with the inclusion of SDP
alone or in combination with BPSBM.
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The second objective of this study was to evaluate the impact of AA source on
PCV2 neutralizing antibodies after vaccination. At both 7 and 14 DPI pigs fed BPSBM
had a greater (P = 0.05) proportion of pigs with higher PCV2 titers than pigs fed CON at
7 and 14 DPI (Fig. 4A and 4B, respectively). We have previously reported that BPSBM
alone may increase adaptive immune response when pigs were sensitized to ovalbumin
(Koepke et al., 2017). With restrictions on antibiotic use in livestock animals it is of
great interest to determine alternative products or diet ingredients that enhance the
immune system. Such tools could be of particular interest when combined with current
tools like vaccination programs that aid in preventing disease outbreaks. The greater
PCV2 neutralizing antibody response in BPSBM fed pigs indicates both an enhanced and
more rapid adaptive immune response.
3.5 CONCLUSION

The similar growth performance of POS pigs further supports the conclusions
from previous work at SDSU that BPSBM can successfully replace SDP and/or FM from
a nutritional perspective. Furthermore, the positive impact of BPSBM inclusion on the
adaptive immune response indicates potential improved disease protection within
commercial vaccination programs.
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Table 3. 1 Ingredient composition and nutrient content of control and experimental diets fed to weaned pigs, as fed basis1.
Phase I
Item
Ingredient (%)
Corn
BPSBM2
Whey, dried
Soya oil
Select Menhaden
fishmeal
Blood plasma3
Soybean meal,
dehulled (46.5%)
L-Lys-HCl
DL-Met
L-Thr
L-Trp
Limestone
Salt
Monocalcium
phosphate
Vitamin premix4
Mineral premix5
Zinc oxide
Formulated content
Total Lys %
SID Lys %
Met + Cys:Lys
ratio, %
Thr:Lys ratio, %
Ile:Lys ratio, %

Phase II

CON

BPSBM+SDP

BPSBM+FM

BPSBM

CON

BPSBM+SDP BPSBM+FM

BPSBM

42.65
25.00
1.25

41.07
7.50
25.00
1.45

37.57
12.00
25.00
1.00

34.40
20.00
25.00
3.40

56.40
10.00
1.00

54.93
5.00
10.00
1.50

51.31
8.00
10.00
1.40

48.02
15.00
10.00
1.80

7.50
6.50

6.50

7.50
-

-

5.00
3.00

3.00

5.00
-

-

15.00
0.05
0.19
0.70
0.25

15.00
0.33
0.19
0.03
0.03
1.20
0.25

15.00
0.04
0.14
0.60
0.25

15.00
0.33
0.17
0.08
0.07
1.10
0.25

22.00
0.18
0.17
1.00
0.25

22.00
0.37
0.15
0.07
0.03
1.20
0.25

22.00
0.09
0.10
0.85
0.25

22.00
0.21
0.10
0.02
1.20
0.25

0.30
0.05
0.15
0.40

0.85
0.05
0.15
0.40

0.30
0.05
0.15
0.40

1.00
0.05
0.15
0.40

0.60
0.05
0.15
0.20

1.10
0.05
0.15
0.20

0.60
0.05
0.15
0.20

1.00
0.05
0.15
0.20

1.78
1.58

1.72
1.56

1.76
1.55

1.72
1.55

1.55
1.37

1.51
1.36

1.56
1.37

1.53
1.36

0.97
1.01
1.10

0.86
0.93
1.12

0.91
0.98
0.97

0.83
0.95
1.01

0.85
0.81
0.87

0.75
0.80
0.89

0.80
0.84
0.88

0.75
0.80
0.94
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Val:Lys ratio, %
Trp:Lys ratio, %
Digestible energy
(kcal/kg)
Lysine: digestible
energy (g/Mcal)
Analyzed
composition (%)
Dry matter
CP
Ash
Crude fat
Crude fiber
Lys

1.15
0.33
3614

1.04
0.31
3573

1.15
0.31
3559

1.03
0.32
3559

0.95
0.27
3541

0.87
0.26
3533

1.00
0.27
3549

0.97
0.26
3537

4.91

4.17

3.93

3.15

4.38

3.86

3.72

3.07

91.89
22.16
6.88
3.73
1.42
1.88

91.70
23.33
6.67
3.72
2.05
1.58

91.85
25.80
6.24
4.31
2.01
1.53

92.98
25.98
6.47
3.64
2.64
1.45

91.13
23.93
6.20
4.13
1.96
1.42

91.00
21.28
5.67
3.65
2.07
1.46

90.78
22.16
6.11
4.06
2.51
1.80

92.03
25.88
6.12
3.59
3.52
1.95

1

Experimental diets were fed from -7 to 0 DPI (Phase I) and from 0 to 14 DPI (Phase II).

2

BPSBM, bio-processed soybean meal (Prairie AquaTech, Brookings, SD, USA).

3

Special Select Menhaden Fish Meal

4

Spray dried porcine plasma

5

Provided per kg of complete diet: 11,002 IU vitamin A supplement, 1651 IU vitamin D3 supplement, 55.1 IU vitamin E supplement,

0.044 mg vitamin B12 supplement, 4.4 mg menadione as menadione dimethylpyrimidinol bisulfite, 9.91 mg riboflavin supplement, 60.6
mg D-pantohenic acid as D-calcium, 55.1 mg niacin supplement, 1.1 mg folic acid, 3.3 mg pyridoxine as pyridoxine hydrochloride, 3.3 mg
thiamine as thiamine mononitrate and 0.171 mg biotin.
6

Provided per kg of the complete diet: 165 mg Zn as zinc sulfate, 165 mg Fe as ferrous sulfate, 43.5 mg Mn as manganese sulfate, 16.5 mg

Cu as basic copper chloride, 0.36 mg I as ethylenediamine dihydriodide and 0.3 mg of Se as sodium selenite.
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Table 3. 2 Effect of dietary inclusion of bio-processed soybean meal (BPSBM) alone or in combination with Menhaden
fishmeal and spray dried porcine plasma on growth performance of uninfected and PRRSV infected weaned pigs1

Item
BW, kg
-7 DPI
0 DPI
7 DPI
14 DPI
ADG, kg/d
-7 to 0 DPI
0 to 7 DPI
7 to 14 DPI
0 to 14 DPI
ADFI, kg/d
-7 to 0 DPI
0 to 7 DPI
7 to 14 DPI
0 to 14 DPI
G:F
-7 to 0 DPI
0 to 7 DPI
7 to 14 DPI
0 to 14 DPI

Uninfected

PRRSV Infected
BPSBM+SDP BPSBM+FM

PRRSV SEM

CON

6.52
7.22
9.84
13.54

7.74
7.75
10.06
13.77

0.39
0.20
0.37
0.77

6.69
7.88
8.93
11.68

6.76
7.87
9.14
12.60

0.06
0.38
0.50
0.45

0.14
0.28
0.53
0.39

0.03
0.03
0.05
0.04

0.10
0.13
0.39
0.27

0.14
0.42
0.70
0.56

0.14
0.42
0.64
0.51

0.01
0.03
0.05
0.04

0.48
0.91
0.78
0.79

0.94
0.67
0.81
0.72

0.17
0.09
0.06
0.04

P-value
Main effects2
PRRSV Diets

BPSBM

SEM

7.79
7.79
8.86
11.93

6.95
7.92
8.73
11.71

1.19
0.19
0.30
0.69

0.026
0.065
0.673
0.830

0.899
0.961
0.766
0.676

0.10
0.23
0.49
0.35

0.08
0.14
0.48
0.29

0.10
0.10
0.41
0.26

0.26
0.08
0.05
0.03

0.039
0.024
0.695
0.303

0.958
0.663
0.362
0.344

0.14
0.28
0.56
0.42

0.14
0.30
0.58
0.44

0.14
0.32
0.61
0.44

0.16
0.28
0.58
0.43

0.02
0.03
0.05
0.03

0.819
0.962
0.384
0.369

0.934
0.644
0.915
0.963

0.50
0.49
0.70
0.64

0.61
0.77
0.85
0.79

0.50
0.43
0.82
0.71

0.62
0.21
0.70
0.61

0.13
0.23
0.07
0.06

0.059
0.057
0.794
0.311

0.777
0.388
0.223
0.142

1

A total of 72 pigs (initial BW 6.68 ± 0.15 kg) were split into a PRRSV challenged group (n = 48) and an uninfected group (SHAM, n =

24) for a 21 d study. Pigs were individually housed (0.56 m2) in separate facilities to reduce the risk of cross infection. Experimental diets
were fed from -7 to 0 DPI (Phase I) and 1 to 14 DPI (Phase II). The control diet (CON) was a corn, soybean meal, whey (25%), FM
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(7.5%) and SDP (6.5%) based diet with decreasing inclusion of whey (10%), FM (5%) and SDP (3%) from Phase I to Phase II,
respectively. The BPSBM replaced FM in the BPSBM+SDP diet, SDP in the BPSBM+FM diet, and both FM and SDP in the BPSBM diet.
2

PRRSV = main effect of disease challenge and Diet = main effect of diet within PRRSV challenged pigs.
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Figure 3. 1

Timeline of porcine reproductive and respiratory virus (PRRSV) inoculation.
Pigs were inoculated with PRRSV at d 0 and BW, rectal temperature and blood were
collected at 0, 3, 7, 10, and 14 d post-inoculation (DPI). Feed disappearance was
measured at 0, 7, and 14 DPI. Pigs were weaned at 21 ± 1 d of age. Experimental diets
were fed in Phase I and II.

63
Figure 3. 2

Serum porcine reproductive and respiratory virus (PRRSV) titers of PRRSV
infected POS pigs at 0, 3, 7, 10, and 14 d post-inoculation (DPI) fed 4 experimental diets.
Data represents lsmeans and standard error of the mean of 12 pigs/dietary treatment.
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Figure 3. 3

Rectal temperatures of porcine reproductive and respiratory virus (PRRSV)
infected and PRRSV uninfected pigs at 0, 3, 7, 10, and 14 d post-inoculation (DPI). Data
points represent lsmeans with error bars representing standard error of the mean (n = 23)
uninfected SHAM pigs and (n = 48) PRRSV infected POS pigs. *The rectal temperature
of PRRSV infected pigs was greater (P<0.001) at 3 DPI and tended to be greater
(P=0.101) at 10 DPI than that of uninfected pigs.
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Figure 3. 4

A

B

Gross and microscopic lung lesion scores of porcine respiratory and reproductive
virus (PRRSV) infected POS pigs fed 4 experimental diets. Data represents the
percentage of animals/dietary treatment (n = 12) on the y-axis that fell within the
respective percent pneumonia range (A) or microscopic lesion score range (B).
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Figure 3. 5

Porcine circovirus type 2 (PCV2) neutralizing antibodies of uninfected pigs
vaccinated with a commercial PCV2 vaccine and fed 2 experimental diets at 14 d postvaccination (A) and 21 d post-vaccination (B). Data represents the percentage of
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animals/dietary treatment (n = 12) with the respective PCV2 neutralizing antibody serum
titer levels.
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Chapter 4
4.0 FINAL DISCUSSION
The primary focus of this thesis was to assess the effects of specialty
amino acid sources on nursery pig immune response during two periods commonly
associated with health challenges: weaning with no imminent disease threat and weaning
during a PRRSV challenge. We hypothesized that inclusion of BPSBM in nursery pig
diets could enhance innate and adaptive immune response of weaned pigs without
adversely impacting pig performance.
Evaluation of both the innate and adaptive immune response is important because
each response plays a different role in how a pig responds to foreign pathogens. The
innate is rapid and non-specific in nature, whereas, the adaptive is slower at first but
forms a memory and is capable of rapid and specific responses upon second exposure.
The adaptive immune system in a weaned pig is not yet fully developed, therefore, they
rely heavily on the innate immune system while the adaptive immunity is maturing
(Dempsey et al., 2003). Upregulation of either the innate or adaptive immune responses
would potentially allow the pig to clear an infection or disease in a shorter period of time
or withstand a larger pathogen load without development of clinical disease. However, a
severe upregulation of the immune system could be detrimental and result in a decrease
in performance, increase in medication use, feed expense, and potentially longer time in
the barn. A slight upregulation; however, could be beneficial by doing the opposite and
allowing the animals to respond more quickly and eliminate any potential immunological
threats they may experience resulting in less medication use, potentially less feed
consumed, and a shorter amount of time in the barn. Ultimately, less expense for the
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producer. There are other factors that are also driving the search for alternative
ingredients like the Veterinary Feed Directive and niche markets promoting pigs fed no
animal bio-products. Reliance on vaccination programs is also likely to increase as a
result of the Veterinary Feed Directive; therefore, products that enhance the immune
system and create better responses when combined with vaccination protocols could be
extremely beneficial for producers. Many of these factors are causing producers to
search for products like BPSBM that can increase pig health without sacrificing
performance. While we utilized different methods to assess innate immune response,
different antigens for adaptive immune response, and more than one ‘stress’ model, the
results of both studies suggest that BPSBM does influence the weaned pig’s immune
response.
The prolonged hypersensitivity response, increased anti-OVA IgG, and increased
proportion of pigs with higher PCV2 neutralizing antibodies all indicate a positive impact
on the adaptive response. It may be argued that the anti-OVA IgG response has limited
practical relevance because OVA is not an industry relevant antigen/pathogen; however,
the higher PCV2 neutralizing antibodies in BPSBM fed pigs in trial 2 supports our
original conclusion using a commercially relevant vaccine. A limitation in the PCV2
neutralizing antibodies assay is the lack of a blood sample before the animals were
vaccinated. This would help us determine if the animals had circulating antibodies to
PCV2 prior to vaccination which they could have received from the colostrum while on
the sow. Further, if the sows had passed on PCV2 antibodies via the colostrum, the
variability could be high depending on the amount of colostrum consumed by the piglets.
Another possible model to assess the adaptive immune response would be using a strep

70
vaccine in a herd that is strep negative. This would eliminate any possibility that the
piglets would have received antigen-specific antibodies from the colostrum and would
allow more sound conclusions to be made. Despite no blood sample prior to vaccination
it is unlikely that any maternal antibodies would have been present at the time of weaning
because maternal antibody absorption is significantly declined after 24 hours of life and
colostrum absorbed antibodies diminished by 14 d (Miller et al., 1962). Therefore, we
still conclude that the BPSBM enhanced the adaptive immune response in weaned pigs.
The lack of differences between treatment groups in lymphocyte proliferation in
the first trial, and rectal temperatures in the second trial, may indicate that BPSBM does
not influence the innate response. However, the lack of difference in lymphocyte
proliferation does not guarantee there was no impact on innate immune response. Prior
to beginning the first experiment we attempted to run a macrophage activity assay;
however, we were unsuccessful. The macrophage activity assay could possibly allow for
a more sensitive detection in differences between treatments by measuring differences in
phagocytic activity. If one treatment increased the phagocytic activity over the another it
would indicate an enhanced innate immune response and therefore a positive benefit to
the pig. Other assays to test innate response such as cytokine expression or innate
immune cell levels/ratios could also help detect more subtle differences between dietary
treatments. Measuring cytokine levels would indicate an inflammatory or antiinflammatory response and be useful in determining if an ingredient is benefiting the
animal or not. Differences in T lymphocyte subset ratios would help indicate what
response (Th1 or Th2) is being driven and help determine under what immunological
challenge conditions (intracellular pathogens vs. extracellular pathogens) a particular
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ingredient would be beneficial to feed (Raymond and Wilkie, 2004). The use of rectal
temperatures as an indirect measure of innate immune response must be considered with
caution because a high temperature can result from extended time under a heat lamp or
the stress of being handled to take the temperature as well as an indicator of fever.
Therefore, we conclude that BPSBM does not influence innate immune response with the
methods used; however, assessment of other variables of innate immune response are
necessary for a definitive conclusion.
Growth performance was not a primary outcome of this project; however, it is
important variable to measure because 1) it can be used as an indicator of successful
disease challenge and 2) it is a practical on-farm variable used to indicate health concern,
or lack thereof. Growth performance in this project supported our respective hypotheses,
in trial 1 no difference in overall performance between groups supported our hypothesis
BPSBM could replace SDP or FM from a nutritional perspective. In trial 2, we also
observed no difference in overall performance between groups; however, it should be
noted there are limitations to the ability to directly translate the trial 2 growth
performance data to a commercial herd because the pigs were housed individually. It
would also be inappropriate to directly translate performance data from the first trial
because the number of animals per pen was significantly less than in a commercial pen.
However, floor space would have been similar and therefore similar growth performance
could be expected based on reports from (Randolph et al., 1981) where reducing floor
space had a greater impact than group size on pig performance.
A follow up study should be conducted to confirm the effects of feeding BPSBM
to weaned pigs in a commercial setting. The change in pen size, feeder
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space/competition, and cleanliness of the barn could change the results but it remains
unclear until it is tested. A commercial nursery trial assessing the effects of feeding
BPSBM on growth performance and neutralizing antibodies to a standard vaccination is
warranted. In conclusion, BPSBM could effectively replace SDP and/or FM with
positive effects on adaptive immune response without sacrificing growth performance.
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